Oncology companies in India, by revenue Browse oncology companies in India by reported revenue, one-year revenue growth, revenue model, age and stage. The 50 companies below are the largest by their most recent reported revenue among 66 oncology companies in India that have filed a figure in the last four years. Every figure keeps its own reporting period, so compare periods before comparing amounts.
Company & business Revenue Revenue growth Headcount & growth Age Jobs · last 3 months
Beta Drugs Developer of therapeutics for oncology and dermatology
Oncology ₹368.79 cr FY 2024-25
+24% 2024–2025
266 +31% 12 mo to Jul 2024LinkedIn · Oct 2026
21 yr 2005
0 none in 3 months
Business facts
Revenue ₹368.79 cr · FY 2024-25
Revenue growth +24% · 2024–2025
Revenue model E-commerce - product, Physical commerce
Team size 380
Recorded funding None recorded
Founded 2005 · about 21 years old
Stage Public
Focus Diversified, Small molecules & peptides, Drugs Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹226.39 cr in FY24-25 · net ₹15.43 cr · +346% since FY2018
Filed standalone accounts · Beta Drugs Limited Leadership · 1 RB Rahul Batra Chairman & Managing Director
Team & hiring signals LinkedIn headcount 266 51-200
LinkedIn followers 5,682
Earlier recorded team 380 2024, a different source
LinkedIn page Technology PHP MySQL Cloudflare WordPress Bootstrap Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Aurigene Clinical-stage biotech company specializing in the discovery and development of novel therapeutics for cancer treatment
Oncology ₹171.93 cr FY 2024-25
-57% 2024–2025
495 +2% 12 mo to Aug 2024recorded Aug 2024
25 yr 2001
0 none in 3 months
Business facts
Revenue ₹171.93 cr · FY 2024-25
Revenue growth -57% · 2024–2025
Revenue model Physical commerce
Team size 495
Recorded funding None recorded
Founded 2001 · about 25 years old
Stage Unfunded
Focus Research services, Diversified Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹171.93 cr in FY24-25 · net −₹81.49 cr · -12% since FY2018
Filed standalone accounts · Aurigene Oncology Limited Leadership · 1
Highest education Doctorates in philosophy · University Of Idaho Technology PHP MySQL Cloudflare WordPress Bootstrap Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Hemogenomics Provider of blood screening technology for the early detection of diseases
Infectious diseases ₹102.89 cr FY 2024-25
+3% 2024–2025
125 -1% 12 mo to Sep 2024LinkedIn · Jul 2026
24 yr 2002
0 none in 3 months
Business facts
Revenue ₹102.89 cr · FY 2024-25
Revenue growth +3% · 2024–2025
Revenue model Subscription
Team size 98
Recorded funding US$219k · Seed · Aug 2008
Founded 2002 · about 24 years old
Stage Seed
Focus In-vitro diagnostic tests, Diversified, In vitro diagnostic tests, Viral Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹102.89 cr in FY24-25 · net ₹7.08 cr · +106% since FY2018
Filed standalone accounts · Hemogenomics Private Limited Leadership · 1 SB Sumit Bagaria CEO & MD
Highest education Master's of business administration in marketing · Indian Institute Of Management, Calcutta
Location Greater Bengaluru Area
Current company Hemogenomics Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 125 51-200
LinkedIn followers 3,705
Earlier recorded team 98 2024, a different source
LinkedIn page Technology PHP MySQL Cloudflare WordPress Bootstrap Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Datar Genetics Provider of liquid biopsy-based cancer diagnostic test
Genomics ₹102.27 cr FY 2024-25
+31% 2024–2025
175 +192% vs previous recordrecorded
34 yr 1992
0 none in 3 months
Business facts
Revenue ₹102.27 cr · FY 2024-25
Revenue growth +31% · 2024–2025
Revenue model Fee-for-service
Team size 175 (previous snapshot 60)
Recorded funding None recorded
Founded 1992 · about 34 years old
Stage Early Stage
Focus Applied genomics, Clinical genomics, Diagnostics, Sequencing-based Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹26.76 cr in FY24-25 · net −₹8.02 cr · +315% since FY2018
Filed standalone accounts · Datar Cancer Genetics Private Limited Founders · 1
Highest education Savitribai Phule Pune University
Location Nasik, Maharashtra, India
Current company Datar Cancer Genetics Limited Profile snapshot · Sep 2026 Technology Cloudflare Bootstrap jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Panacea Developer of devices for radiotherapy
Women health ₹86.35 cr FY 2022-23
Not reported
11 +4% 12 mo to Jul 2024LinkedIn · Oct 2026
27 yr 1999
— No postings tracked
Business facts
Revenue ₹86.35 cr · FY 2022-23
Revenue growth Not reported
Revenue model E-commerce - product, Physical commerce
Team size 336
Recorded funding None recorded
Founded 1999 · about 27 years old
Stage Series B
Focus Medical devices, Screening devices, Breast cancer, Therapies Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹99.58 cr in FY24-25 · net ₹6.67 cr · +243% since FY2018
Filed standalone accounts · Panacea Medical Technologies Private Limited Founders · 2 GV G V Subrahmanyam Co-Founder & Managing Director
RP Raghu Padmanabhan Co-Founder & CEO
Investors · 2 Tara Fund Fund
Team & hiring signals LinkedIn headcount 11 201-500
LinkedIn followers 2,939
Earlier recorded team 336 2024, a different source
LinkedIn page Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
ImmunoACT Developer of cell and gene therapies for cancer treatment
Oncology ₹67.57 cr FY 2024-25
+510% 2024–2025
193 +96% 12 mo to Sep 2024LinkedIn · Jul 2026
8 yr 2018
0 none in 3 months · last posted Jun 2026
Business facts
Revenue ₹67.57 cr · FY 2024-25
Revenue growth +510% · 2024–2025
Revenue model Fee-for-service
Team size 139
Recorded funding US$15.87m · Series B · May 2023
Founded 2018 · about 8 years old
Stage Series B
Focus Drugs, Blood cancer Revenue over time FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹67.57 cr in FY24-25 · net ₹10.18 cr · +287274% since FY2021
Filed standalone accounts · Immunoadoptive Cell Therapy Private Limited Funding over time Series A · Nov 2021 A '21 Series B · May 2023 B '23 US$15.87m across 2 disclosed equity rounds
Darker bars = larger rounds Founders · 3 AK Atharva Karulkar Co-Founder
Highest education Doctor of Philosophy · Indian Institute of Technology Bombay
Location Mumbai, Maharashtra, India Profile snapshot · Sep 2026 RP Rahul Purwar Co-Founder & CEO
Highest education Master's of Science · University of Lucknow
Location Mumbai, Maharashtra, India
Current company Indian Institute of Technology, Bombay Profile snapshot · Sep 2026 SA Shirish Arya Co-Founder & Director - Corporate Strategy & Business Development
Highest education MBA · IMDR
Team & hiring signals LinkedIn headcount 193 51-200
LinkedIn followers 37,682
Earlier recorded team 139 2024, a different source
Open roles 1 of 5 tracked · last posted Jun 2026
Jun 2026 Hiring: Receptionist · Navi Mumbai, MaharashtraJun 2026 Hiring: Strategic Accounts Lead · Cambridge, Navi Mumbai, MaharashtraLinkedIn page Recent company signals Jun 2026 Milestone 750+ patients treatedFrom the company’s LinkedIn posts Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Zuvius Lifesciences Research-based pharmaceutical company specializing in chemotherapeutic formulations and nutraceuticals
Oncology ₹39.04 cr FY 2023-24
+38% 2023–2024
64 +16% 12 mo to Sep 2024LinkedIn · Jul 2026
21 yr 2005
0 none in 3 months
Business facts
Revenue ₹39.04 cr · FY 2023-24
Revenue growth +38% · 2023–2024
Revenue model E-commerce - product, Physical commerce
Team size 36
Recorded funding None recorded
Founded 2005 · about 21 years old
Stage Unfunded
Focus Dietary supplements, Disease specific, Cancer, Drugs Revenue over time FY2017 17 FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 ₹39.04 cr in FY23-24 · net ₹1.85 cr · +200% since FY2017
Filed standalone accounts · Zuvius Lifesciences Private Limited Founders · 2
Location Mumbai, Maharashtra, India
Current company Zuvius Lifesciences Pvt. Ltd. Profile snapshot · Sep 2026 NT Nimish Thakkar Co-Founder & CEO
Team & hiring signals LinkedIn headcount 64 51-200
LinkedIn followers 2,872
Earlier recorded team 36 2024, a different source
LinkedIn page Technology PHP MySQL Cloudflare WordPress Bootstrap Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Levim Lifetech Developer of biopharmaceutics to address various health conditions
Diabetes ₹30.91 cr FY 2024-25
Not reported
— Not available
10 yr 2016
1 postings · last posted Sep 2026
Business facts
Revenue ₹30.91 cr · FY 2024-25
Revenue growth Not reported
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding None recorded
Founded 2016 · about 10 years old
Stage Funding Raised
Focus Drugs, Blood cancer Founders · 2 NV Nitin Vimal Co-Founder
Highest education Harvard University
Location Chennai, Tamil Nadu, India
Current company Levim Lifetech Pvt Ltd Profile snapshot · Sep 2026 Team & hiring signals Open roles 1 of 1 tracked · last posted Sep 2026
Technology PHP MySQL Nginx Cloudflare WordPress Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Medion Biotech Manufacturer of oncology medicines, including injectables and oral solid dosages
Oncology ₹29.50 cr FY 2024-25
+1% 2024–2025
41 LinkedIn · Jul 2026
14 yr 2012
0 none in 3 months
Business facts
Revenue ₹29.50 cr · FY 2024-25
Revenue growth +1% · 2024–2025
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding None recorded
Founded 2012 · about 14 years old
Stage Unfunded
Focus Diversified, Drugs Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹29.50 cr in FY24-25 · net ₹76.59 lakh · +1170% since FY2018
Filed standalone accounts · Medion Biotech Private Limited Team & hiring signals LinkedIn headcount 41 51-200
LinkedIn followers 1,262
LinkedIn page Technology PHP MySQL WordPress Bootstrap jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Bugworks Research Developer of drugs for antibiotic-resistant bacterial infections and cancer
Infectious diseases ₹25.18 cr FY 2024-25
-12% 2024–2025
47 +11% 12 mo to Aug 2023LinkedIn · Jul 2026
12 yr 2014
0 none in 3 months
Business facts
Revenue ₹25.18 cr · FY 2024-25
Revenue growth -12% · 2024–2025
Revenue model Physical commerce
Team size 31 (previous snapshot 45)
Recorded funding US$42.89m · Series B · Feb 2024
Founded 2014 · about 12 years old
Stage Series B
Focus Drugs, Bacterial, Drug resistant infections, Diversified Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹25.18 cr in FY24-25 · net ₹2.46 cr · +282% since FY2018
Filed standalone accounts · Bugworks Research India Private Limited Funding over time Seed · Nov 2015 Seed '15 Series A · Aug 2018 A '18 Series B · Apr 2020 B '20 Series B · Dec 2021 B '21 Series B · Feb 2024 B '24 US$42.89m across 5 disclosed equity rounds
Darker bars = larger rounds Founders · 3 BS Bala Subramanian Co-Founder & COO
Highest education BSc · Loyola College
Location Bengaluru, Karnataka, India Profile snapshot · Sep 2026 SD Santanu Datta Co-Founder
Highest education Calcutta University, Kolkata
Location Bengaluru, Karnataka, India
Current company Bugworks Research Inc. Profile snapshot · Sep 2026 AA Anand Anandkumar Co-Founder & CEO
Highest education Doctor of Philosophy · The George Washington University Team & hiring signals LinkedIn headcount 47 11-50
LinkedIn followers 11,353
Earlier recorded team 31 2023, a different source
LinkedIn page Recent company signals Apr 2026 Milestone global patenting of BWC2094 program BWC2094 patentingFrom the company’s LinkedIn posts Technology PHP MySQL Cloudflare WordPress jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
4baseCare Provider of precision oncology solutions, including genomic testing and digital health
Oncology ₹14.27 cr FY 2024-25
Not reported
322 LinkedIn · Jul 2026
8 yr 2018
0 none in 3 months · last posted Jul 2026
Business facts
Revenue ₹14.27 cr · FY 2024-25
Revenue growth Not reported
Revenue model Subscription
Team size 25
Recorded funding US$22.28m · Series B · Jan 2026
Founded 2018 · about 8 years old
Stage Series B
Focus Applied genomics, Clinical genomics, Diagnostics, Sequencing-based Funding over time Angel · Feb 2019 Angel '19 Seed · Mar 2021 Seed '21 Series A · Jul 2024 A '24 Series A · Dec 2024 A '24 Series A · Nov 2025 A '25 Series B · Jan 2026 B '26 US$22.28m across 6 disclosed equity rounds
Darker bars = larger rounds Founders · 2 HG Hitesh Goswami Co-Founder & CEO
Highest education Sophia College, Mumbai
Location Bengaluru, Karnataka, India
Current company 4baseCare Profile snapshot · Sep 2026 KR Kshitij Rishi Co-Founder & COO
Highest education B.E. · Panjab University
Team & hiring signals LinkedIn headcount 322 51-200
LinkedIn followers 39,764
Open roles 4 of 10 tracked · last posted Jul 2026
LinkedIn page Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Curadev Pharma Developer of small molecule immunotherapy drugs for cancer and inflammation
Immunotherapy ₹14.08 cr FY 2024-25
+24% 2024–2025
42 -19% 12 mo to Sep 2024LinkedIn · Jul 2026
16 yr 2010
0 none in 3 months · last posted Jul 2026
Business facts
Revenue ₹14.08 cr · FY 2024-25
Revenue growth +24% · 2024–2025
Revenue model Fee-for-service
Team size 38 (previous snapshot 40)
Recorded funding US$881k · Angel · Mar 2011
Founded 2010 · about 16 years old
Stage Seed
Focus Drugs, Diversified Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹14.08 cr in FY24-25 · net −₹20.93 cr · +580% since FY2018
Filed standalone accounts · Curadev Pharma Private Limited Founders · 2
Highest education MS · Indian Institute of Technology Kanpur
MT Manish Tandon Director and Co-Founder
Highest education Wharton Executive Education
Location Boston, Massachusetts, United States
Current company CURADEV PHARMA Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 42 51-200
LinkedIn followers 9,006
Earlier recorded team 38 2024, a different source
Open roles 3 of 4 tracked · last posted Jul 2026
Jun 2026 Hiring: Research Biologist · Noida, Uttar PradeshJun 2026 Hiring: Laboratory Technician · Noida, Uttar Pradesh, IndiaMay 2026 Hiring: Clinical Trial Assistant (CTA) · Noida / New DelhiLinkedIn page Patents Patent filings 87
Focus: Small‑molecule STING antagonists and ACSS2 inhibitors for immuno‑oncology therapy
CPC C07D333/66, C07D417/12, C08B37/0012 Technology Google Cloud React Sentry Bootstrap Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
BioGenomics Developer of recombinant DNA-based biosimilars, recombinant proteins, and enzymes
Diabetes ₹10.70 cr FY 2022-23
Not reported
288 -8% 12 mo to Sep 2024LinkedIn · Jul 2026
24 yr 2002
0 none in 3 months · last posted Mar 2026
Business facts
Revenue ₹10.70 cr · FY 2022-23
Revenue growth Not reported
Revenue model Physical commerce
Team size 136
Recorded funding US$24.62m · Seed · Jul 2022
Founded 2002 · about 24 years old
Stage Seed
Focus Drugs, Diversified Revenue over time FY2016 16 FY2017 17 FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 ₹10.70 cr in FY22-23 · net −₹30.77 cr · +206% since FY2016
Filed standalone accounts · Biogenomics Limited Founders · 1 SS Sanjay Sonar Co-Founder & Owner & President & CEO
Highest education IIT Bombay
Location Thane, Maharashtra, India
Current company BioGenomics Limited Profile snapshot · Sep 2026 Investors · 2 EA Eagle Asia Holding Fund
Team & hiring signals LinkedIn headcount 288 201-500
LinkedIn followers 23,784
Earlier recorded team 136 2024, a different source
Open roles 1 of 2 tracked · last posted Mar 2026
LinkedIn page Patents Patent filings 34
Focus: Recombinant protein expression systems and insulin/analog production technologies
CPC C07K1/1136, C07K14/62, C12N15/70 Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Perfint Healthcare Developer of solutions for image-guided interventional procedures
Oncology ₹10.70 cr FY 2024-25
+45% 2024–2025
150 +3% 12 mo to Jun 2024LinkedIn · Jul 2026
21 yr 2005
1 postings · last posted Aug 2026
Business facts
Revenue ₹10.70 cr · FY 2024-25
Revenue growth +45% · 2024–2025
Revenue model E-commerce - product, Physical commerce
Team size 31 (previous snapshot 201)
Recorded funding US$41.48m · Series D · Apr 2017
Founded 2005 · about 21 years old
Stage Series D
Focus Medical devices, Imaging, Diversified, Computerized tomography Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹10.70 cr in FY24-25 · net ₹1.26 cr · -29% since FY2018
Filed standalone accounts · Perfint Healthcare Private Limited Funding over time Series A · Nov 2009 A '09 Series A · Mar 2010 A '10 Series B · Jun 2010 B '10 Series C · Dec 2011 C '11 Series C · Mar 2012 C '12 Series D · Jan 2013 D '13 Series D · Jan 2015 D '15 Series D · Jun 2016 D '16 Series D · Apr 2017 D '17 US$41.48m across 10 disclosed equity rounds
Darker bars = larger rounds Founders · 2 GK Gopalkrishna Kulkarni ex-Co-Founder
Highest education Pgdbm · ERNET India
Location Bengaluru, Karnataka, India Profile snapshot · Sep 2026 NS Nandakumar Subburaman Co-Founder & CEO
Investors · 4 A EV Erasmic Venture Fund Fund
Team & hiring signals LinkedIn headcount 150 51-200
LinkedIn followers 13,468
Earlier recorded team 31 2024, a different source
Open roles 3 of 7 tracked · last posted Aug 2026
May 2026 Hiring: Junior Stores Executive · ChennaiMay 2026 Hiring: CSR FacilitatorMay 2026 Internship: Sales InternLinkedIn page Patents Patent filings 28
Focus: Robotic and sensor‑guided needle positioning for image‑guided minimally invasive procedures
CPC A61B34/10, A61B17/3403, A61B5/0084 Technology Cloudflare Bootstrap jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
OncoStem Developer of prognostic tests for the detection of cancer
Oncology ₹10.02 cr FY 2024-25
+40% 2024–2025
22 +12% 12 mo to Sep 2024LinkedIn · Jul 2026
15 yr 2011
0 none in 3 months
Business facts
Revenue ₹10.02 cr · FY 2024-25
Revenue growth +40% · 2024–2025
Revenue model Subscription
Team size 19
Recorded funding US$9.00m · Series A · Sep 2017
Founded 2011 · about 15 years old
Stage Series A
Focus In-vitro diagnostic tests, Women's cancer, Breast cancer, Prognosis Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹10.02 cr in FY24-25 · net ₹3.71 cr · +187% since FY2018
Filed standalone accounts · Oncostem Diagnostics Private Limited Funding over time Seed · Jan 2011 Seed '11 Series A · Sep 2017 A '17 US$9.00m across 2 disclosed equity rounds
Darker bars = larger rounds Founders · 1 MB Manjiri Bakre Founder & CEO
Location Bengaluru, Karnataka, India Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 22 11-50
LinkedIn followers 6,955
Earlier recorded team 19 2024, a different source
LinkedIn page Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Immuneel Developer of T-cell therapies for the treatment of cancer
Oncology ₹9.92 cr FY 2024-25
+342% 2024–2025
112 -24% 12 mo to Aug 2024LinkedIn · Jul 2026
8 yr 2018
0 none in 3 months
Business facts
Revenue ₹9.92 cr · FY 2024-25
Revenue growth +342% · 2024–2025
Revenue model Fee-for-service
Team size 67 (previous snapshot 50)
Recorded funding US$39.34m · Series A · Jun 2024
Founded 2018 · about 8 years old
Stage Series A
Focus Drugs, Diversified Revenue over time FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹9.92 cr in FY24-25 · net −₹40.46 cr · +1378% since FY2020
Filed standalone accounts · Immuneel Therapeutics Private Limited Funding over time Series A · Nov 2019 A '19 Series A · Sep 2020 A '20 Series A · Apr 2022 A '22 Series A · Jun 2024 A '24 US$39.34m across 4 disclosed equity rounds
Darker bars = larger rounds Founders · 1 SM Siddhartha Mukherjee Co-Founder
Location New York, New York, United States
Current company Columbia University Medical Center Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 112 51-200
LinkedIn followers 73,120
Earlier recorded team 67 2024, a different source
LinkedIn page Recent company signals Jun 2026 Leadership Hired a Associate Director – Global Market AccessFrom the company’s LinkedIn posts Technology PHP MySQL Salesforce WordPress Bootstrap Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
CuraTeQ Biologics Developer of immuno-oncology therapeutics
Oncology ₹9.49 cr FY 2024-25
Not reported
696 +25% 12 mo to Sep 2024LinkedIn · Oct 2026
6 yr 2020
0 none in 3 months · last posted Apr 2025
Business facts
Revenue ₹9.49 cr · FY 2024-25
Revenue growth Not reported
Revenue model E-commerce - product, Physical commerce
Team size 535
Recorded funding None recorded
Founded 2020 · about 6 years old
Stage Unfunded
Focus Drugs, Diversified, Immuno oncology Revenue over time FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹9.49 cr in FY24-25 · net −₹812.07 cr · -81% since FY2021
Filed standalone accounts · Curateq Biologics Private Limited Team & hiring signals LinkedIn headcount 696 501-1,000
LinkedIn followers 19,558
Earlier recorded team 535 2024, a different source
Open roles 0 of 1 tracked · last posted Apr 2025
LinkedIn page Recent company signals Sep 2025 Milestone completed Phase III clinical study completedFrom the company’s LinkedIn posts Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Issar Pharmaceuticals Developer of customied peptide-based therapeutic products
Oncology ₹8.31 cr FY 2023-24
Not reported
22 -88% 12 mo to Aug 2022LinkedIn · Jul 2026
31 yr 1995
0 none in 3 months
Business facts
Revenue ₹8.31 cr · FY 2023-24
Revenue growth Not reported
Revenue model E-commerce - product, Physical commerce
Team size 2
Recorded funding None recorded
Founded 1995 · about 31 years old
Stage Unfunded
Focus Drugs, Diversified, Pan cancer Revenue over time FY2015 15 FY2016 16 FY2017 17 FY2018 18 FY2019 19 FY2020 20 FY2021 21 ₹25.56 cr in FY20-21 · net ₹12.21 cr · +322% since FY2015
Filed standalone accounts · Issar Pharmaceuticals Private Limited Founders · 1 RI Ram Isanaka Founder and Chairman
Highest education The City University of New York
Location Hyderabad, Telangana, India
Current company Issar Pharmaceuticals Pvt. Ltd. Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 22 51-200
LinkedIn followers 724
Earlier recorded team 2 2022, a different source
LinkedIn page Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
6iPAIN HELATHCARE Provider of pain management solution for oncology, critical care and anaesthesia
Neurology ₹6.92 cr FY 2021-22
Not reported
— Not available
8 yr 2018
0 none in 3 months
Business facts
Revenue ₹6.92 cr · FY 2021-22
Revenue growth Not reported
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding None recorded
Founded 2018 · about 8 years old
Stage Unfunded
Focus Drugs, Pan cancer, Anaesthesia, Pain Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
SATYA Pharma Innovations Developer of small molecules for the treatment of cancer
Oncology ₹7.55 cr FY 2024-25
+24% 2024–2025
41 -19% 12 mo to Jul 2024LinkedIn · Jul 2026
7 yr 2019
0 none in 3 months · last posted Sep 2025
Business facts
Revenue ₹7.55 cr · FY 2024-25
Revenue growth +24% · 2024–2025
Revenue model Physical commerce
Team size 38
Recorded funding None recorded
Founded 2019 · about 7 years old
Stage Unfunded
Focus Drugs, Diversified Revenue growth Latest revenue ₹7.55 cr FY 2024-25
1y growth +24%
3y growth +298%
5y growth -2%
Reported compound annual growth Founders · 1 MC Murthy Chavali Founder & CEO
Team & hiring signals LinkedIn headcount 41 11-50
LinkedIn followers 3,104
Earlier recorded team 38 2024, a different source
Open roles 0 of 1 tracked · last posted Sep 2025
Sep 2025 Hiring: AccountantLinkedIn page Technology PHP Cloudflare Bootstrap jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Sekkei Bio Developer of drugs and vaccines to treat multiple diseases
Diabetes ₹7.55 cr FY 2024-25
+255% 2024–2025
22 LinkedIn · Jul 2026
9 yr 2017
0 none in 3 months · last posted Apr 2026
Business facts
Revenue ₹7.55 cr · FY 2024-25
Revenue growth +255% · 2024–2025
Revenue model Fee-for-service
Team size Not available
Recorded funding US$2.03m · Seed · Feb 2021
Founded 2017 · about 9 years old
Stage Series A
Focus Drugs, Diversified, Viral Revenue over time FY2019 19 FY2020 20 FY2021: no filing on record 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹7.55 cr in FY24-25 · net −₹1.96 cr · +6190% since FY2019
Filed standalone accounts · Sekkei Bio Private Limited Funding over time Series A · Jan 2021 A '21 Seed · Feb 2021 Seed '21 US$2.03m across 2 disclosed equity rounds
Darker bars = larger rounds Founders · 1 MC Monalisa Chatterji Co-Founder
Highest education MSc · Indian Institute of Science
Location Bangalore Urban, Karnataka, India
Current company Sekkei Bio Private Limited Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 22 11-50
LinkedIn followers 2,736
Open roles 1 of 2 tracked · last posted Apr 2026
Apr 2026 Hiring: Upstream ScientistApr 2026 Hiring: Project Lead · Bangalore, IndiaLinkedIn page Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Epigeneres Provider of genomics based diagnostic tests for cancer
Oncology ₹7.42 cr FY 2024-25
+185% 2024–2025
85 +0% 12 mo to Sep 2024LinkedIn · Jul 2026
18 yr 2008
0 none in 3 months · last posted May 2026
Business facts
Revenue ₹7.42 cr · FY 2024-25
Revenue growth +185% · 2024–2025
Revenue model E-commerce - product, Physical commerce
Team size 75
Recorded funding US$9.83m · Series B · Jun 2024
Founded 2008 · about 18 years old
Stage Series B
Focus In-vitro diagnostic tests, Pan cancer Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹7.42 cr in FY24-25 · net −₹17.26 cr · +8079% since FY2018
Filed standalone accounts · Epigeneres Biotech Private Limited Funding over time Series A · Apr 2018 A '18 Series B · Dec 2021 B '21 Series B · Jun 2024 B '24 US$9.83m across 3 disclosed equity rounds
Darker bars = larger rounds Founders · 1 AT Ashish Tripathi Founder & Chairman
Highest education Master's of business administration in finance · Melbourne Business School
Location Mumbai, Maharashtra, India
Current company Tzar Labs Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 85 51-200
LinkedIn followers 5,100
Earlier recorded team 75 2024, a different source
Open roles 2 of 3 tracked · last posted May 2026
May 2026 Hiring: Junior Legal ExecutiveApr 2026 Hiring: Clinical Oncology LiaisonApr 2026 Hiring: Business Development Manager · Mumbai, Bengaluru, New DelhiLinkedIn page Technology React Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
PredOmix Developer of cancer detection blood test
Oncology ₹6.98 cr FY 2024-25
+6% 2024–2025
9 LinkedIn · Jul 2026
8 yr 2018
0 none in 3 months
Business facts
Revenue ₹6.98 cr · FY 2024-25
Revenue growth +6% · 2024–2025
Revenue model Subscription
Team size 17
Recorded funding US$662k · Seed · Jun 2019
Founded 2018 · about 8 years old
Stage Seed
Focus In-vitro diagnostic tests, Diversified Revenue over time FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹6.98 cr in FY24-25 · net −₹8.41 lakh · +139% since FY2021
Filed standalone accounts · Predomix Technologies Private Limited Founders · 1 KR Kanury Rao Co-Founder
Highest education Savitribai Phule Pune University
Location Gurgaon, Haryana, India
Current company PredOmix Technologies Pvt. Ltd. Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 9 2-10
LinkedIn followers 535
Earlier recorded team 17 2024, a different source
LinkedIn page Technology PHP Cloudflare Bootstrap jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Zumutor Developer of novel immunotherapy and monoclonal antibody therapeutics
Immunotherapy ₹4.63 cr FY 2024-25
-64% 2024–2025
25 -20% 12 mo to Jun 2023LinkedIn · Jul 2026
13 yr 2013
0 none in 3 months
Business facts
Revenue ₹4.63 cr · FY 2024-25
Revenue growth -64% · 2024–2025
Revenue model Fee-for-service
Team size 24 (previous snapshot 37)
Recorded funding US$27.89m · Series A · Nov 2024
Founded 2013 · about 13 years old
Stage Series A
Focus Drugs, Diversified, Immuno oncology Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹4.63 cr in FY24-25 · net −₹3.90 cr · -52% since FY2018
Filed standalone accounts · Zumutor Biologics Private Limited Funding over time Seed · Jan 2013 Seed '13 Series A · Jan 2015 A '15 Series A · Apr 2018 A '18 Series A · Nov 2019 A '19 Series A · Aug 2021 A '21 Series A · Oct 2022 A '22 Series A · Feb 2024 A '24 Series A · Nov 2024 A '24 US$27.89m across 8 disclosed equity rounds
Darker bars = larger rounds Founders · 2 KI Kavitha Iyer Rodrigues Co-Founder & CEO
Highest education Master's of Business Administration, Management · Indian Institute of Management Bangalore
Location Greater Bengaluru Area
Current company Zumutor Biologics Inc. Profile snapshot · Sep 2026
Highest education Wright State University Boonshoft School Of Medicine
Location Bengaluru, Karnataka, India
Current company Zumutor Biologics Inc. Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 25 11-50
LinkedIn followers 8,561
Earlier recorded team 24 2023, a different source
LinkedIn page Technology PHP MySQL Cloudflare WordPress Bootstrap Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Transcell Biolife Developer of stem cell technologies to screen small molecules for solid tumors
Life sciences platforms and tools ₹4.04 cr FY 2022-23
+3% 2022–2023
2 -50% 12 mo to Oct 2020recorded Oct 2020
13 yr 2013
0 none in 3 months
Business facts
Revenue ₹4.04 cr · FY 2022-23
Revenue growth +3% · 2022–2023
Revenue model Fee-for-service
Team size 2
Recorded funding None recorded
Founded 2013 · about 13 years old
Stage Seed
Focus Drugs, Pan cancer, Diversified Revenue over time FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 ₹4.04 cr in FY22-23 · net −₹3.24 cr · +304% since FY2019
Filed standalone accounts · Transcell Oncologics Private Limited Founders · 1 SD Subhadra Dravida Founder
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Ricaptos Developer of drugs for oncology, cardiovascular, gastroenterology disease, and infectious diseases
Oncology 1 LinkedIn · Jul 2026
7 yr 2019
0 none in 3 months
Business facts Revenue growth ●●●●
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding None recorded
Founded 2019 · about 7 years old
Stage Unfunded
Focus Drugs, Diversified Revenue over time FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Ricaptos Biocare Private Limited Founders · 1
Location Bengaluru, Karnataka, India
Current company Ricaptos Biocare Pvt Ltd. Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 1 201-500
LinkedIn followers 15
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Sapien Biosciences Provider of biobanking services to discover biomarkers and develop drugs and companion diagnostics
Oncology 50 +17% 12 mo to Sep 2024LinkedIn · Jul 2026
14 yr 2012
0 none in 3 months
Business facts Revenue growth ●●●●
Revenue model Physical commerce, Subscription
Team size 42
Recorded funding None recorded
Founded 2012 · about 14 years old
Stage Seed
Focus Research services, Biorepository, Gene biobanking, Enabling technologies Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Sapien Biosciences Private Limited Founders · 2 JJ Jugnu Jain Co-Founder & CEO
Highest education PhD, Genetics · University of Cambridge
Location Hyderabad, Telangana, India
Current company Sapien Biosciences Profile snapshot · Sep 2026 VN Vatsa Natarajan Co-Founder & Director
Highest education MSc · BITS Pilani
Location Hyderabad, Telangana, India Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 50 11-50
LinkedIn followers 7,516
Earlier recorded team 42 2024, a different source
LinkedIn page Technology PHP MySQL Sentry WordPress jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Rapid Biopharma Specializes in generics formulation
Oncology 8 LinkedIn · Jul 2026
14 yr 2012
0 none in 3 months
Business facts Revenue growth ●●●●
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding None recorded
Founded 2012 · about 14 years old
Stage Unfunded
Focus Drugs, Diversified Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Rapid Biopharma Private Limited Team & hiring signals LinkedIn headcount 8
LinkedIn followers 23
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Lamark Biotech Developer of thermostable biologics for treating diabetes and other diseases
Ophthalmology Not reported
12 LinkedIn · Jul 2026
8 yr 2018
2 postings · last posted Aug 2026
Business facts
Revenue growth Not reported
Revenue model Physical commerce
Team size 8
Recorded funding US$983k · Seed · Jan 2025
Founded 2018 · about 8 years old
Stage Seed
Focus Drugs, Diversified Revenue over time FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Lamark Biotech Private Limited Funding over time Seed · Mar 2021 Seed '21 Seed · Apr 2023 Seed '23 Seed · Jan 2025 Seed '25 US$983k across 3 disclosed equity rounds
Darker bars = larger rounds Founders · 1 VB Vaibhav Bhatia Founder & CEO
Highest education PhD · Indian Institute of Science
Location Greater Sevilla Metropolitan Area
Current company Lamark Biotech Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 12 2-10
LinkedIn followers 2,376
Open roles 2 of 4 tracked · last posted Aug 2026
LinkedIn page Patents Patent filings 4
Focus: Controlled-release insulin formulations using hydrogel crystal‑seeding technology
CPC C07K14/62 Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Invictus Oncology Developer of chemotherapeutics conjugated with antibodies for the treatment of cancer
Immunotherapy 16 +12% 12 mo to Mar 2019LinkedIn · Jul 2026
15 yr 2011
0 none in 3 months
Business facts Revenue growth ●●●●
Revenue model E-commerce - product, Physical commerce
Team size 38
Recorded funding US$6.99m · Series A · Oct 2016
Founded 2011 · about 15 years old
Stage Series A
Focus Drugs, Diversified Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Invictus Oncology Private Limited Funding over time Series A · Feb 2013 A '13 Series A · May 2014 A '14 Series A · Aug 2015 A '15 Series A · Jun 2016 A '16 Series A · Oct 2016 A '16 US$6.99m across 5 disclosed equity rounds
Darker bars = larger rounds Founders · 1 RM Raghunath Mashelkar Co-Founder
Team & hiring signals LinkedIn headcount 16 2-10
LinkedIn followers 523
Earlier recorded team 38 2019, a different source
LinkedIn page Patents Patent filings 51
Focus: Lipid‑nanoparticle delivery of platinum chemotherapeutics and signaling‑inhibitor therapeutics
CPC C07F15/0093, A61K31/337, A61K47/60 Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Eva Scalp Cooling Manufacturer of scalp cooling systems designed to minimize chemotherapy-induced hair loss
Oncology 27 LinkedIn · Jul 2026
6 yr 2020
0 none in 3 months
Business facts Revenue growth ●●●●
Revenue model Subscription
Team size Not available
Recorded funding None recorded
Founded 2020 · about 6 years old
Stage Funding Raised
Focus Medical devices, Therapies, Chemotherapy, Therapy complications Revenue over time FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Stemtech Medical Devices Private Limited Founders · 1 RS Raghuveer Surupa Founder
Highest education Marketing · Indian Institute Of Management, Ranchi
Location Mumbai, Maharashtra, India
Current company Stemtech Medical Devices Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 27 2-10
LinkedIn followers 2,893
LinkedIn page Technology PHP MySQL Cloudflare WordPress Bootstrap Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Boltzmann AI powered drug discovery platform for cancer and autoimmune diseases
Life sciences tech 50 LinkedIn · Jul 2026
7 yr 2019
0 none in 3 months
Agentic AI Software
Close × Business facts Revenue growth ●●●●
Revenue model Subscription
Team size Not available
Recorded funding US$113k · Angel · Sep 2022
Founded 2019 · about 7 years old
Stage Seed
Focus Research & development, Drug discovery, Cheminformatics, Lead discovery Revenue over time FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Boltzmann Labs Private Limited Funding over time Angel · Mar 2021 Angel '21 Angel · Sep 2022 Angel '22 US$113k across 2 disclosed equity rounds
Darker bars = larger rounds Founders · 2 PP Paritosh Prashar Co-Founder & CSO
Highest education Indian Institute of Technology Kanpur KS Kolli Sarath Co-Founder & CEO
Highest education Master's of Technology · IIT Bombay
Location Bengaluru, Karnataka, India
Current company Boltzmann Profile snapshot · Sep 2026 Investors · 2 MV Madala Vineeth Angel
Team & hiring signals LinkedIn headcount 50 11-50
LinkedIn followers 7,712
LinkedIn page Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
TeraLumen Provider of terahertz-based non-destructive testing systems for industrial and biomedical applications
Manufacturing tech 6 recorded
7 yr 2019
0 none in 3 months
Business facts Revenue growth ●●●●
Revenue model Subscription
Team size 6
Recorded funding None recorded
Founded 2019 · about 7 years old
Stage Funding Raised
Focus Medical devices, Imaging, Breast cancer, Screening devices Revenue over time FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Teralumen Solutions Private Limited Founders · 1 JD Jyotirmayee Dash Co-Founder & CEO
Highest education Master's in engineering · Anna University
Location Chennai, Tamil Nadu, India
Current company TeraLumen Solutions Pvt. Ltd. Profile snapshot · Sep 2026 Patents Patent filings 3
Focus: Patents concentrated in health & consumer products
CPC A61B5/0507, G01N21/3586 Technology PHP MySQL Cloudflare WordPress jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Impetis Manufacturer of therapeutic drugs
Immunology 2 +0% 12 mo to Mar 2019recorded Mar 2019
10 yr 2016
0 none in 3 months
Business facts Revenue growth ●●●●
Revenue model E-commerce - product, Physical commerce
Team size 2
Recorded funding None recorded
Founded 2016 · about 10 years old
Stage Unfunded
Focus Drugs, Diversified, Immuno oncology, Autoimmune diseases Revenue over time FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Impetis Biosciences Limited Technology Node.js Express Nginx jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Sāscan Developer of screening devices for the detection of cancer
Oncology Not reported
20 LinkedIn · Jul 2026
11 yr 2015
0 none in 3 months · last posted May 2026
Business facts
Revenue growth Not reported
Revenue model Subscription
Team size 16
Recorded funding US$339k · Seed · Apr 2021
Founded 2015 · about 11 years old
Stage Seed
Focus Medical devices, Imaging, Diversified Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Sascan Meditech Private Limited Funding over time Seed · May 2018 Seed '18 Seed · May 2020 Seed '20 Seed · Apr 2021 Seed '21 US$339k across 3 disclosed equity rounds
Darker bars = larger rounds Founders · 1 SN Subhash Narayanan Founder and CEO
Highest education Doctorates in physics · Cochin University Of Science & Technology, Kochi
Location Thiruvananthapuram, Kerala, India
Current company Sascan Meditech Pvt. Ltd. Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 20 11-50
LinkedIn followers 1,948
Open roles 1 of 1 tracked · last posted May 2026
May 2026 Hiring: Software Developer · ThiruvananthapuramLinkedIn page Recent company signals Jun 2026 Award Indian Patent for Non-invasive multispectral imaging camera for cervical cancer detection — Indian Council of Medical ResearchFrom the company’s LinkedIn posts Technology PHP MySQL Cloudflare WordPress jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
APAC Biotech Developer of autologous monocyte-derived dendritic cell immunotherapy for cancer
Immunotherapy — Not available
16 yr 2010
0 none in 3 months
Business facts Revenue growth ●●●●
Revenue model Physical commerce
Team size Not available
Recorded funding US$991k · Seed · Mar 2011
Founded 2010 · about 16 years old
Stage Seed
Focus Drugs, Diversified Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Apac Biotech Private Limited Investors · 1 Projects Development Fund
Technology Google Cloud React Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Prosetta Developer of anti-viral therapies
Infectious diseases 4 LinkedIn · Jul 2026
22 yr 2004
0 none in 3 months
Business facts Revenue growth ●●●●
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding None recorded
Founded 2004 · about 22 years old
Stage Unfunded
Focus Drugs, Diversified, Neurodegenerative Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Prosetta Bio-Conformatics Private Limited Founders · 1 KM Karl Manheim Co-Founder
Location Los Angeles, California, United States
Current company Seldom Here Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 4
LinkedIn followers 41
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Mestastop Developer of cell-based functional assays for cancer metastasis focused drug discovery and predictive diagnostics
Life sciences platforms and tools 23 LinkedIn · Jul 2026
8 yr 2018
0 none in 3 months
Business facts Revenue growth ●●●●
Revenue model Fee-for-service
Team size 12
Recorded funding US$1.29m · Seed · May 2024
Founded 2018 · about 8 years old
Stage Seed
Focus Research assays, Drug discovery, Organoid models, Patient derived cancer cell models Revenue over time FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Mestastop Solutions Private Limited Funding over time Angel · Jul 2020 Angel '20 Seed · Dec 2020 Seed '20 Seed · Aug 2023 Seed '23 Seed · Dec 2023 Seed '23 Seed · May 2024 Seed '24 US$1.29m across 5 disclosed equity rounds
Darker bars = larger rounds Founders · 2 DC Debabani Chowdhury Co-Founder
Highest education Manimala Girls' High School
Location Bengaluru, Karnataka, India
Current company Mestastop Solutions Profile snapshot · Sep 2026 AC Arnab Chowdhury Co-Founder
Location Bengaluru, Karnataka, India
Current company Mestastop Solutions Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 23 11-50
LinkedIn followers 2,832
LinkedIn page Recent company signals Jan 2026 Milestone 67% of journey completed, another 3 years milestoneFrom the company’s LinkedIn posts Patents Patent filings 9
Focus: AI-based cancer metastasis prediction platforms and repurposed drug screening for metastasis inhibition
CPC G16H50/20, A61P35/00, A61P35/04 Technology PHP MySQL Cloudflare WordPress Bootstrap Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Transgene Biotek Developer of immunotherapies and drug delivery solutions for cancer
Genomics 20 LinkedIn · Oct 2026
36 yr 1990
0 none in 3 months
Business facts Revenue growth ●●●●
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding None recorded
Founded 1990 · about 36 years old
Stage Public
Focus Applied genomics, Clinical genomics, Therapeutics, Drugs Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Transgene Biotek Limited. Founders · 1 KR Koteswara Rao Founder & Managing Director
Location Hyderabad, Telangana, India
Current company Transgene Biotek Ltd Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 20 51-200
LinkedIn followers 510
LinkedIn page Patents Patent filings 25
Focus: Advanced oral and nasal peptide drug delivery formulations for insulin and biologics
CPC A61K47/36, A61K38/28, C07K7/08 Technology Cloudflare Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Tvaster Genkalp Developer of epigenetic-based liquid biopsy tests for cancer detection. This company provides molecular diagnostic solutions focusing on identifying genetic and epigenetic modifications to aid oncologists in making informed treatment decisions. The tests utilize a minimally invasive blood sample to diagnose and understand genetic and epigenetic alterations, enabling personalized healthcare decisions. The technology combines epigenetics, liquid biopsy, and digital droplet PCR for efficient cancer screening. The company's mission is to provide clinically relevant information to improve the quali
Oncology 4 +300% 12 mo to Sep 2024recorded Sep 2024
5 yr 2021
0 none in 3 months
Business facts Revenue growth ●●●●
Revenue model Advertising, Commission on transaction, E-commerce - product
Team size 4
Recorded funding US$2.57m · Seed · Apr 2025
Founded 2021 · about 5 years old
Stage Seed
Focus In-vitro diagnostic tests, Gastrointestinal cancer, Liver cancer, In vitro diagnostic tests Revenue over time FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Tvaster Genkalp Private Limited Funding over time Seed · Sep 2023 Seed '23 Seed · Apr 2025 Seed '25 US$2.57m across 2 disclosed equity rounds
Darker bars = larger rounds Founders · 2 SR Srikar Raman Co-Founder & CEO
Highest education Doctorates in mechanical engineering · University Of Illinois At Chicago
Location Chennai, Tamil Nadu, India
Current company Tvaster Genkalp Profile snapshot · Sep 2026 SK Sreedurgalakshmi K Co-Founder
Highest education Master's of Technology · SRM
Location Chennai, Tamil Nadu, India
Current company Tvaster Genkalp Profile snapshot · Sep 2026 Investors · 4 IS Invigo Softwares Fund
RH Rela Hospitals Fund
MR Mohamed Rela Angel
Patents Patent filings 3
Focus: Epigenetic diagnostic kits detecting carcinomas via methylation markers without sequencing
CPC C12Q1/6886, C12Q1/6858 Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Luxmatra Developer of therapeutics for multiple diseases
Oncology Not reported
— Not available
—
— No postings tracked
Business facts
Revenue growth Not reported
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding None recorded
Founded Not available
Stage Funding Raised
Focus Drugs, Diversified, Immuno oncology Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Luxmatrainnovations Private Limited Founders · 2 MK Manzoor Koyakutty Co-Founder & Director
Highest education Cochin University of Science and Technology
Location Ernakulam, Kerala, India
Current company The Johns Hopkins University School of Medicine Profile snapshot · Sep 2026 GC Girish C M Co-Founder & COO
Highest education MIT Professional Education
Location Ernakulam, Kerala, India
Current company Luxmatra Innovations Profile snapshot · Sep 2026 Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Kyvor Genomics-based precision cancer diagnostics
Genomics 2 LinkedIn · Jul 2026
10 yr 2016
0 none in 3 months
Business facts Revenue growth ●●●●
Revenue model Subscription
Team size 11
Recorded funding US$160k · Angel · Jul 2017
Founded 2016 · about 10 years old
Stage Seed
Focus In-vitro diagnostic tests, Pan cancer, Applied genomics, Clinical genomics Revenue over time FY2017 17 FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022: no filing on record 22 FY2023 23 FY2024 24 ●●●● ●●●● ●●●●
Filed standalone accounts · Kyvor Genomics Private Limited Founders · 1 AM Abilesh Malli Gunasekar Founder & CEO
Highest education The University of Manchester
Location Chennai, Tamil Nadu, India
Current company Kyvor Genomics, Inc Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 2 11-50
LinkedIn followers 2,986
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
ExoCan Exosomes based oncodiagnostics and therapeutics healthcare technology solutions provider
Oncology — Not available
11 yr 2015
0 none in 3 months
Business facts Revenue growth ●●●●
Revenue model Physical commerce, Subscription
Team size Not available
Recorded funding None recorded
Founded 2015 · about 11 years old
Stage Funding Raised
Focus In-vitro diagnostic tests, Diversified, Applied genomics, Clinical genomics Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Exocan Healthcare Technologies Private Limited Founders · 1 AS Aman Sharma Founder & Director
Location Pune District, Maharashtra, India Profile snapshot · Sep 2026 Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Aindra Provider of AI-powered cervical cancer detection system
Oncology 24 LinkedIn · Jul 2026
14 yr 2012
0 none in 3 months
Consumer Social impact Software Hardware
Close × Business facts Revenue growth ●●●●
Revenue model Subscription
Team size 20
Recorded funding US$304k · Angel · Jun 2021
Founded 2012 · about 14 years old
Stage Seed
Focus In-vitro diagnostic tests, Women's cancer, Cervical cancer, Pathology Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Aindra Systems Private Limited Funding over time Seed · May 2016 Seed '16 Angel · Nov 2018 Angel '18 Angel · Jun 2019 Angel '19 Angel · Jun 2021 Angel '21 US$304k across 4 disclosed equity rounds
Darker bars = larger rounds Founders · 1 AN Adarsh Natarajan Founder & Co-Owner & CEO
Highest education Cambridge Judge Business School
Location Bengaluru, Karnataka, India
Current company AIndra Systems Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 24 11-50
LinkedIn followers 11,294
LinkedIn page Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Positive Bioscience Provider of DNA tests for cancer treatment & hereditary cancer screening
Genomics 14 +38% 12 mo to Jul 2023LinkedIn · Jul 2026
14 yr 2012
0 none in 3 months
Business facts Revenue growth ●●●●
Revenue model Subscription
Team size 11 (previous snapshot 31)
Recorded funding US$466k · Angel · Nov 2018
Founded 2012 · about 14 years old
Stage Seed
Focus In-vitro diagnostic tests, Diversified, Enabling technologies, Kits and reagents Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Positive Biosciences Limited Founders · 3 SJ Samarth Jain Co-Founder & CEO
Highest education MIT Professional Education
Location Mumbai, Maharashtra, India
Current company Positive Bioscience Profile snapshot · Sep 2026 BJ Bapsy Jain Co-Founder & CFO
Location Mumbai, Maharashtra, India
Current company S P Jain School of Global Management Profile snapshot · Sep 2026 MM Meetha Medhora Co-Founder
Highest education Genetics · Washington University In St. Louis
Location Brookfield, Wisconsin, United States Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 14 11-50
LinkedIn followers 3,736
Earlier recorded team 11 2023, a different source
LinkedIn page Technology PHP MySQL Nginx WordPress jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
East Ocyon Bio Developer of cell and gene therapies for the treatment of cancer
Oncology 35 LinkedIn · Jul 2026
4 yr 2022
0 none in 3 months · last posted Sep 2025
Business facts Revenue growth ●●●●
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding US$4.20m · Seed · Dec 2024
Founded 2022 · about 4 years old
Stage Seed
Focus Drugs, Diversified Revenue over time FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · East Ocyon Bio Private Limited Founders · 2 NM Narinder Mehra Co-Founder & Director
DK Dinesh Kundu Co-Founder & Director
Highest education MBA · London Business School
Location Gurgaon, Haryana, India Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 35 11-50
LinkedIn followers 1,266
Open roles 0 of 1 tracked · last posted Sep 2025
Sep 2025 Hiring: Research Scientist · FaridabadLinkedIn page Technology React Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
NKure Theraputics Developer of NK cell therapies for the treatment of cancer
Cell therapy 15 LinkedIn · Jul 2026
5 yr 2021
0 none in 3 months
Business facts Revenue growth ●●●●
Revenue model Fee-for-service
Team size 3
Recorded funding US$2.15m · Seed · Oct 2023
Founded 2021 · about 5 years old
Stage Seed
Focus Drugs, Diversified Revenue over time FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Nkure Therapeutics Private Limited Funding over time Seed · Dec 2022 Seed '22 Seed · Apr 2023 Seed '23 Seed · Oct 2023 Seed '23 US$2.15m across 3 disclosed equity rounds
Darker bars = larger rounds Founders · 2 AV Ashok Vohra Co-Founder
Highest education BSc, Engineering · Greater Brighton Metropolitan College
Location Bengaluru, Karnataka, India
Current company NKure Therapeutics Profile snapshot · Sep 2026
Highest education Caltech
Location Washington DC-Baltimore Area
Current company Forza Bio Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 15 2-10
LinkedIn followers 1,676
LinkedIn page Recent company signals Nov 2025 Award Best poster award — DBR MAHE Cell Therapy ConclaveFrom the company’s LinkedIn posts Technology PHP MySQL WordPress Bootstrap jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Aten Porus Lifesciences Developer of therapeutics for rare and complex diseases
Rare diseases 23 +38% 12 mo to Jun 2024LinkedIn · Jul 2026
13 yr 2013
0 none in 3 months
Business facts Revenue growth ●●●●
Revenue model Physical commerce
Team size 33
Recorded funding None recorded
Founded 2013 · about 13 years old
Stage Funding Raised
Focus Drugs, Diversified, Immuno oncology Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Aten Porus Lifesciences Private Limited Founders · 3 NS Namala Srinivasan Co-Founder
Highest education Master's of Science · Northeastern University AK Aditya Kulkarni Co-Founder
Highest education Purdue University
Location Bengaluru, Karnataka, India Profile snapshot · Sep 2026 AP Arun Papaiah Co-Founder & CEO
Team & hiring signals LinkedIn headcount 23 11-50
LinkedIn followers 4,836
Earlier recorded team 33 2024, a different source
LinkedIn page Technology Cloudflare Bootstrap jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
ByLin Medtech Developer of drug delivery technology for xerostomia treatment
Drug delivery — Not available
6 yr 2020
0 none in 3 months
Business facts Revenue growth ●●●●
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding None recorded
Founded 2020 · about 6 years old
Stage Funding Raised
Focus Drugs, Therapy complications, Patches Revenue over time FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Bylin Medtech Private Limited Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Advait Theragnostics Developer of therapeutics for cancer and inflammatory diseases
Oncology 5 LinkedIn · Jul 2026
7 yr 2019
0 none in 3 months · last posted Jun 2026
Business facts Revenue growth ●●●●
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding None recorded
Founded 2019 · about 7 years old
Stage Funding Raised
Focus Drugs, Diversified Revenue over time FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Advait Theragnostics Private Limited Team & hiring signals LinkedIn headcount 5 11-50
LinkedIn followers 835
Open roles 2 of 2 tracked · last posted Jun 2026
Jun 2026 Hiring: Statistical Programmer / AnalystLinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
No matching company in this list.
Fliar Radar Explore all 107 oncology companies in India on Radar This page shows the top 50. Radar has the complete, filterable list with contacts and live company signals.
Open oncology in India on Radar Every company, not just 50 All 107 oncology companies in India, filterable by stage, funding, team size, revenue model and age. Founders and decision-makers Leadership teams with roles and verified LinkedIn profiles, ready for outreach. Live signals Funding rounds, hiring, launches and M&A as they happen, with alerts on the companies you follow. Save and export Build lists, compare companies side by side and export them from your Radar account. Explore oncology companies in India by what you are looking for Find top oncology companies in India, from cancer drug developers and oncology manufacturers to genomic diagnostics firms. Browse oncology startups in India and cancer therapy companies by type.
7 ways to explore oncology in India Cancer drug & therapeutics developers Cancer genomics & diagnostic companies Immunotherapy, cell & gene therapy companies Cancer screening, imaging & radiotherapy devices Cancer research, biobanking & life sciences tools Oncology startups in India Hide Cancer drug & therapeutics developers Companies developing and manufacturing oncology drugs and biologics.
Beta Drugs Developer of therapeutics for oncology and dermatology
Oncology See in list Aurigene Clinical-stage biotech company specializing in the discovery and development of novel therapeutics for cancer treatment
Oncology See in list Datar Genetics Provider of liquid biopsy-based cancer diagnostic test
Genomics See in list Panacea Developer of devices for radiotherapy
Women health See in list ImmunoACT Developer of cell and gene therapies for cancer treatment
Oncology See in list Cancer genomics & diagnostic companies Liquid biopsy, genomic testing and in-vitro diagnostics for cancer detection.
Hemogenomics Provider of blood screening technology for the early detection of diseases
Infectious diseases See in list Datar Genetics Provider of liquid biopsy-based cancer diagnostic test
Genomics See in list 4baseCare Provider of precision oncology solutions, including genomic testing and digital health
Oncology See in list OncoStem Developer of prognostic tests for the detection of cancer
Oncology See in list Epigeneres Provider of genomics based diagnostic tests for cancer
Oncology See in list Immunotherapy, cell & gene therapy companies Developers of CAR-T, immuno-oncology and other cell and gene therapies.
ImmunoACT Developer of cell and gene therapies for cancer treatment
Oncology See in list CuraTeQ Biologics Developer of immuno-oncology therapeutics
Oncology See in list Zumutor Developer of novel immunotherapy and monoclonal antibody therapeutics
Immunotherapy See in list Impetis Manufacturer of therapeutic drugs
Immunology See in list Aten Porus Lifesciences Developer of therapeutics for rare and complex diseases
Rare diseases See in list Cancer screening, imaging & radiotherapy devices Medical devices for cancer screening, imaging and radiation therapy.
Panacea Developer of devices for radiotherapy
Women health See in list Perfint Healthcare Developer of solutions for image-guided interventional procedures
Oncology See in list Eva Scalp Cooling Manufacturer of scalp cooling systems designed to minimize chemotherapy-induced hair loss
Oncology See in list TeraLumen Provider of terahertz-based non-destructive testing systems for industrial and biomedical applications
Manufacturing tech See in list Sāscan Developer of screening devices for the detection of cancer
Oncology See in list Cancer research, biobanking & life sciences tools Research services, cell models and biobanks that support cancer research.
Sapien Biosciences Provider of biobanking services to discover biomarkers and develop drugs and companion diagnostics
Oncology See in list Boltzmann AI powered drug discovery platform for cancer and autoimmune diseases
Life sciences tech See in list Mestastop Developer of cell-based functional assays for cancer metastasis focused drug discovery and predictive diagnostics
Life sciences platforms and tools See in list Positive Bioscience Provider of DNA tests for cancer treatment & hereditary cancer screening
Genomics See in list Foresight Biotech Developer of technologies to use nucleic acids as drugs
Life sciences platforms and tools Website Oncology startups in India Newer oncology companies in India founded in recent years.
Tvaster Genkalp Developer of epigenetic-based liquid biopsy tests for cancer detection. This company provides molecular diagnostic solutions focusing on identifying genetic and epigenetic modifications to aid oncologists in making informed treatment decisions. The tests utilize a minimally invasive blood sample to diagnose and understand genetic and epigenetic alterations, enabling personalized healthcare decisions. The technology combines epigenetics, liquid biopsy, and digital droplet PCR for efficient cancer screening. The company's mission is to provide clinically relevant information to improve the quali
Oncology See in list East Ocyon Bio Developer of cell and gene therapies for the treatment of cancer
Oncology See in list Genoscope Developer of saliva-based diagnostic tests for head and neck cancer
Oncology Website Exsure Developer of nano drug delivery platform for cancer treatment
Oncology Website MagHeals Provider of magnetic hyperthermia therapy device to treat cancer
Oncology Website Oncology companies hiring in India Oncology firms in India with open jobs right now.
ImmunoACT Developer of cell and gene therapies for cancer treatment
Oncology See in list Levim Lifetech Developer of biopharmaceutics to address various health conditions
Diabetes See in list 4baseCare Provider of precision oncology solutions, including genomic testing and digital health
Oncology See in list Curadev Pharma Developer of small molecule immunotherapy drugs for cancer and inflammation
Immunotherapy See in list BioGenomics Developer of recombinant DNA-based biosimilars, recombinant proteins, and enzymes
Diabetes See in list The business behind the activity Oncology financials in India Revenue, profit and growth from the filed annual accounts of 54 oncology companies in India for FY24-25 — 69 of the 107 companies on this page file accounts with the Ministry of Corporate Affairs. The five largest earn 74% of the revenue, so medians describe the typical company better than totals.
combined revenue, FY24-25 ₹897.21 cr 54 companies filing accounts
combined net profit −₹961.03 cr -107.1% aggregate margin
are profitable 37% 20 of 54 companies
median revenue ~₹1.6 cr the typical company
median revenue growth +22% into FY24-25
earned by the top five 74% revenue concentration
Six-year view
Combined revenue of filing companies ₹765.45 cr FY19-20 43 filers
₹756.06 cr FY20-21 47 filers
₹783.51 cr FY21-22 52 filers
₹913.36 cr FY22-23 57 filers
₹1,020.40 cr FY23-24 56 filers
₹897.21 cr FY24-25 54 filers
The number of companies filing changes each year; the three-year cohort below compares like with like.
Like-for-like
The same 48 companies over three years -0%
FY22-23 ₹868.99 cr −₹568.03 cr net
FY23-24 ₹980.33 cr −₹688.88 cr net
FY24-25 ₹865.53 cr −₹951.43 cr net Companies with accounts for all three years, so growth is not an artefact of who filed.
Scale and profit
Bigger companies are far more often profitable Under ₹1 cr 21 24% profitable
₹1–10 cr 21 29% profitable
₹10–100 cr 9 78% profitable
₹100–1,000 cr 3 67% profitable
Over ₹1,000 cr 0 —
Companies by FY24-25 revenue. Bars show how many companies sit in each band.
Momentum
How fast revenue moved into FY24-25 Shrinking 14
0–20% 11
20–50% 5
50–100% 2
Doubled+ 19
51 companies with accounts for both years; median growth +22%.
Profitability
Profit is concentrated at the top 20 profitable
34 loss-making
-107.1% aggregate margin
-25.7% median margin
The aggregate margin is pulled up by a few large filers; the median shows the typical company.
Growth leaders · ₹10 cr+ revenue
Fastest growing, FY24-25 Profit leaders · ₹10 cr+ revenue
Highest net margins, FY24-25 Inside the industry
Sub-sectors compared, FY24-25 Leaders
Largest oncology companies by revenue, FY24-25 Standalone annual accounts filed with the Ministry of Corporate Affairs. Brands that share one legal entity are shown together and counted once.
Capital & corporate activity Oncology funding and M&A across India 116 recorded equity rounds have gone to 126 oncology companies in India — how much, at which stage, into which sub-sectors, from whom, and how India compares. Debt, IPO and grant rounds are excluded.
equity rounds, last 12 months 3 US$12.81m
equity rounds, last 24 months 14 US$42.24m
raised over five years US$167.05m 53 rounds in India
M&A deals, India 2 last 24 months
Capital by year
Equity funding into oncology in India $16m 2018 8
$16m 2019 9
$9.4m 2020 11
$41m 2021 14
$41m 2022 7
$14m 2023 9
$54m 2024 13
$6.1m 2025 8
$12m 2026 2
Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2024, with US$53.81m across 13 rounds.
The funding ladder · five years
Rounds and typical cheque by stage Angel US$217k 4 rounds · median US$52k
Seed US$43.13m 30 rounds · median US$622k
Series A US$71.45m 13 rounds · median US$3.39m
Series B US$52.26m 6 rounds · median US$8.23m
Where the money went · five years
Most-funded sub-sectors Oncology US$87.51m 30 rounds · 14 companies
Diabetes US$26.66m 4 rounds · 2 companies
Infectious diseases US$24.78m 2 rounds · 1 companies
Genomics US$16.00m 1 rounds · 1 companies
Immunotherapy US$7.89m 4 rounds · 1 companies
Cell therapy US$2.15m 3 rounds · 1 companies
Ophthalmology US$983k 3 rounds · 1 companies
India in context
India’s share of India’s oncology funding Rounds 100% 53 of 53
Capital 100% US$167.05m of US$167.05m
Equity rounds over the last five years, 126 oncology companies in India among 126 in India.
Corporate activity · last 24 months
M&A in India Most active acquirers CuraTeQ Biologics 1 Access pharmaceuticals 1 Most acquired or merged CuraTeQ Biologics s.r.o. 1 Somanta pharmaceuticals 1 Each deal appears in the events strip at the top of the page.
Oncology funding in India 37 oncology companies in India have recorded equity funding, US$289.09m in total. Totals and round dates describe the historical record; they are not current valuations.
Most funded Largest recorded equity totals, with the latest recorded round.
Infectious diseases Bugworks Research Developer of drugs for antibiotic-resistant bacterial infections and cancer
Recorded equity funding US$42.89m Series B · Feb 2024
SD Explore company Oncology Perfint Healthcare Developer of solutions for image-guided interventional procedures
Recorded equity funding US$41.48m Series D · Apr 2017
Explore company Oncology Immuneel Developer of T-cell therapies for the treatment of cancer
Recorded equity funding US$39.34m Series A · Jun 2024
Founder · 1
SM Explore company Immunotherapy Zumutor Developer of novel immunotherapy and monoclonal antibody therapeutics
Recorded equity funding US$27.89m Series A · Nov 2024
KI Explore company Diabetes BioGenomics Developer of recombinant DNA-based biosimilars, recombinant proteins, and enzymes
Recorded equity funding US$24.62m Seed · Jul 2022
Founder · 1
SS Explore company Oncology 4baseCare Provider of precision oncology solutions, including genomic testing and digital health
Recorded equity funding US$22.28m Series B · Jan 2026
KR Kshitij Rishi Co-Founder & COO
Explore company Genomics 1Cell.Ai Developer of AI-powered single-cell multi-omic analysis tools for precision oncology
Recorded equity funding US$16.00m Series A · Nov 2024
Founder · 1
MU Explore company Oncology ImmunoACT Developer of cell and gene therapies for cancer treatment
Recorded equity funding US$15.87m Series B · May 2023
RP SA Shirish Arya Co-Founder & Director - Corporate Strategy & Business Development
Explore company Oncology Epigeneres Provider of genomics based diagnostic tests for cancer
Recorded equity funding US$9.83m Series B · Jun 2024
Founder · 1
AT Explore company Oncology OncoStem Developer of prognostic tests for the detection of cancer
Recorded equity funding US$9.00m Series A · Sep 2017
Explore company Immunotherapy Invictus Oncology Developer of chemotherapeutics conjugated with antibodies for the treatment of cancer
Recorded equity funding US$6.99m Series A · Oct 2016
Founder · 1
RM Raghunath Mashelkar Co-Founder
Explore company Oncology Cellogen Therapeutics Developer of cellular engineering methods and gene therapy based treatments
Recorded equity funding US$4.69m Series A · May 2026
Explore company Oncology Theramyt Novobiologics Developer of treatment-altering biological drugs for multiple diseases
Recorded equity funding US$4.40m Series A · Sep 2013
Founders
Details not available
Explore company Oncology East Ocyon Bio Developer of cell and gene therapies for the treatment of cancer
Recorded equity funding US$4.20m Seed · Dec 2024
NM Narinder Mehra Co-Founder & Director
Explore company Oncology Tvaster Genkalp Developer of epigenetic-based liquid biopsy tests for cancer detection. This company provides molecular diagnostic solutions focusing on identifying genetic and epigenetic modifications to aid oncologists in making informed treatment decisions. The tests utilize a minimally invasive blood sample to diagnose and understand genetic and epigenetic alterations, enabling personalized healthcare decisions. The technology combines epigenetics, liquid biopsy, and digital droplet PCR for efficient cancer screening. The company's mission is to provide clinically relevant information to improve the quali
Recorded equity funding US$2.57m Seed · Apr 2025
SR SK Explore company Oncology Erly Sign A platform providing test kits for detecting oral cancer
Recorded equity funding US$2.17m Seed · Jan 2025
DB Explore company Radar Every funded oncology company in India Filter by stage, investor and round date. Open in Radar → Business facts
Revenue ₹25.18 cr · FY 2024-25
Revenue growth -12% · 2024–2025
Revenue model Physical commerce
Team size 31 (previous snapshot 45)
Recorded funding US$42.89m · Series B · Feb 2024
Founded 2014 · about 12 years old
Stage Series B
Focus Drugs, Bacterial, Drug resistant infections, Diversified Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹25.18 cr in FY24-25 · net ₹2.46 cr · +282% since FY2018
Filed standalone accounts · Bugworks Research India Private Limited Funding over time Seed · Nov 2015 Seed '15 Series A · Aug 2018 A '18 Series B · Apr 2020 B '20 Series B · Dec 2021 B '21 Series B · Feb 2024 B '24 US$42.89m across 5 disclosed equity rounds
Darker bars = larger rounds Founders · 3 BS Bala Subramanian Co-Founder & COO
Highest education BSc · Loyola College
Location Bengaluru, Karnataka, India Profile snapshot · Sep 2026 SD Santanu Datta Co-Founder
Highest education Calcutta University, Kolkata
Location Bengaluru, Karnataka, India
Current company Bugworks Research Inc. Profile snapshot · Sep 2026 AA Anand Anandkumar Co-Founder & CEO
Highest education Doctor of Philosophy · The George Washington University Team & hiring signals LinkedIn headcount 47 11-50
LinkedIn followers 11,353
Earlier recorded team 31 2023, a different source
LinkedIn page Recent company signals Apr 2026 Milestone global patenting of BWC2094 program BWC2094 patentingFrom the company’s LinkedIn posts Technology PHP MySQL Cloudflare WordPress jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹10.70 cr · FY 2024-25
Revenue growth +45% · 2024–2025
Revenue model E-commerce - product, Physical commerce
Team size 31 (previous snapshot 201)
Recorded funding US$41.48m · Series D · Apr 2017
Founded 2005 · about 21 years old
Stage Series D
Focus Medical devices, Imaging, Diversified, Computerized tomography Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹10.70 cr in FY24-25 · net ₹1.26 cr · -29% since FY2018
Filed standalone accounts · Perfint Healthcare Private Limited Funding over time Series A · Nov 2009 A '09 Series A · Mar 2010 A '10 Series B · Jun 2010 B '10 Series C · Dec 2011 C '11 Series C · Mar 2012 C '12 Series D · Jan 2013 D '13 Series D · Jan 2015 D '15 Series D · Jun 2016 D '16 Series D · Apr 2017 D '17 US$41.48m across 10 disclosed equity rounds
Darker bars = larger rounds Founders · 2 GK Gopalkrishna Kulkarni ex-Co-Founder
Highest education Pgdbm · ERNET India
Location Bengaluru, Karnataka, India Profile snapshot · Sep 2026 NS Nandakumar Subburaman Co-Founder & CEO
Investors · 4 A EV Erasmic Venture Fund Fund
Team & hiring signals LinkedIn headcount 150 51-200
LinkedIn followers 13,468
Earlier recorded team 31 2024, a different source
Open roles 3 of 7 tracked · last posted Aug 2026
May 2026 Hiring: Junior Stores Executive · ChennaiMay 2026 Hiring: CSR FacilitatorMay 2026 Internship: Sales InternLinkedIn page Patents Patent filings 28
Focus: Robotic and sensor‑guided needle positioning for image‑guided minimally invasive procedures
CPC A61B34/10, A61B17/3403, A61B5/0084 Technology Cloudflare Bootstrap jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹9.92 cr · FY 2024-25
Revenue growth +342% · 2024–2025
Revenue model Fee-for-service
Team size 67 (previous snapshot 50)
Recorded funding US$39.34m · Series A · Jun 2024
Founded 2018 · about 8 years old
Stage Series A
Focus Drugs, Diversified Revenue over time FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹9.92 cr in FY24-25 · net −₹40.46 cr · +1378% since FY2020
Filed standalone accounts · Immuneel Therapeutics Private Limited Funding over time Series A · Nov 2019 A '19 Series A · Sep 2020 A '20 Series A · Apr 2022 A '22 Series A · Jun 2024 A '24 US$39.34m across 4 disclosed equity rounds
Darker bars = larger rounds Founders · 1 SM Siddhartha Mukherjee Co-Founder
Location New York, New York, United States
Current company Columbia University Medical Center Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 112 51-200
LinkedIn followers 73,120
Earlier recorded team 67 2024, a different source
LinkedIn page Recent company signals Jun 2026 Leadership Hired a Associate Director – Global Market AccessFrom the company’s LinkedIn posts Technology PHP MySQL Salesforce WordPress Bootstrap Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹4.63 cr · FY 2024-25
Revenue growth -64% · 2024–2025
Revenue model Fee-for-service
Team size 24 (previous snapshot 37)
Recorded funding US$27.89m · Series A · Nov 2024
Founded 2013 · about 13 years old
Stage Series A
Focus Drugs, Diversified, Immuno oncology Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹4.63 cr in FY24-25 · net −₹3.90 cr · -52% since FY2018
Filed standalone accounts · Zumutor Biologics Private Limited Funding over time Seed · Jan 2013 Seed '13 Series A · Jan 2015 A '15 Series A · Apr 2018 A '18 Series A · Nov 2019 A '19 Series A · Aug 2021 A '21 Series A · Oct 2022 A '22 Series A · Feb 2024 A '24 Series A · Nov 2024 A '24 US$27.89m across 8 disclosed equity rounds
Darker bars = larger rounds Founders · 2 KI Kavitha Iyer Rodrigues Co-Founder & CEO
Highest education Master's of Business Administration, Management · Indian Institute of Management Bangalore
Location Greater Bengaluru Area
Current company Zumutor Biologics Inc. Profile snapshot · Sep 2026
Highest education Wright State University Boonshoft School Of Medicine
Location Bengaluru, Karnataka, India
Current company Zumutor Biologics Inc. Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 25 11-50
LinkedIn followers 8,561
Earlier recorded team 24 2023, a different source
LinkedIn page Technology PHP MySQL Cloudflare WordPress Bootstrap Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹10.70 cr · FY 2022-23
Revenue growth Not reported
Revenue model Physical commerce
Team size 136
Recorded funding US$24.62m · Seed · Jul 2022
Founded 2002 · about 24 years old
Stage Seed
Focus Drugs, Diversified Revenue over time FY2016 16 FY2017 17 FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 ₹10.70 cr in FY22-23 · net −₹30.77 cr · +206% since FY2016
Filed standalone accounts · Biogenomics Limited Founders · 1 SS Sanjay Sonar Co-Founder & Owner & President & CEO
Highest education IIT Bombay
Location Thane, Maharashtra, India
Current company BioGenomics Limited Profile snapshot · Sep 2026 Investors · 2 EA Eagle Asia Holding Fund
Team & hiring signals LinkedIn headcount 288 201-500
LinkedIn followers 23,784
Earlier recorded team 136 2024, a different source
Open roles 1 of 2 tracked · last posted Mar 2026
LinkedIn page Patents Patent filings 34
Focus: Recombinant protein expression systems and insulin/analog production technologies
CPC C07K1/1136, C07K14/62, C12N15/70 Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹14.27 cr · FY 2024-25
Revenue growth Not reported
Revenue model Subscription
Team size 25
Recorded funding US$22.28m · Series B · Jan 2026
Founded 2018 · about 8 years old
Stage Series B
Focus Applied genomics, Clinical genomics, Diagnostics, Sequencing-based Funding over time Angel · Feb 2019 Angel '19 Seed · Mar 2021 Seed '21 Series A · Jul 2024 A '24 Series A · Dec 2024 A '24 Series A · Nov 2025 A '25 Series B · Jan 2026 B '26 US$22.28m across 6 disclosed equity rounds
Darker bars = larger rounds Founders · 2 HG Hitesh Goswami Co-Founder & CEO
Highest education Sophia College, Mumbai
Location Bengaluru, Karnataka, India
Current company 4baseCare Profile snapshot · Sep 2026 KR Kshitij Rishi Co-Founder & COO
Highest education B.E. · Panjab University
Team & hiring signals LinkedIn headcount 322 51-200
LinkedIn followers 39,764
Open roles 4 of 10 tracked · last posted Jul 2026
LinkedIn page Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue Not reported
Revenue growth Not reported
Revenue model Subscription
Team size Not available
Recorded funding US$16.00m · Series A · Nov 2024
Founded 2021 · about 5 years old
Stage Series A
Focus Applied genomics, Clinical genomics, Diagnostics, Diversified Founders · 1 MU Mohan Uttarwar Co-Founder & CEO
Highest education MS · VJTI Mumbai
Location Cupertino, California, United States
Current company 1Cell.Ai Inc. Profile snapshot · Sep 2026 Investors · 5 CC CS E Eragon Fund
Team & hiring signals LinkedIn headcount 196 51-200
LinkedIn followers 13,866
Open roles 2 of 4 tracked · last posted Aug 2026
LinkedIn page Mobile apps DrG Health & Fitness · 117 installs · updated 2026-06-05 oSakhi Medical · 14 installs · updated 2026-06-03 Google Play Technology PHP MySQL Cloudflare WordPress jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹67.57 cr · FY 2024-25
Revenue growth +510% · 2024–2025
Revenue model Fee-for-service
Team size 139
Recorded funding US$15.87m · Series B · May 2023
Founded 2018 · about 8 years old
Stage Series B
Focus Drugs, Blood cancer Revenue over time FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹67.57 cr in FY24-25 · net ₹10.18 cr · +287274% since FY2021
Filed standalone accounts · Immunoadoptive Cell Therapy Private Limited Funding over time Series A · Nov 2021 A '21 Series B · May 2023 B '23 US$15.87m across 2 disclosed equity rounds
Darker bars = larger rounds Founders · 3 AK Atharva Karulkar Co-Founder
Highest education Doctor of Philosophy · Indian Institute of Technology Bombay
Location Mumbai, Maharashtra, India Profile snapshot · Sep 2026 RP Rahul Purwar Co-Founder & CEO
Highest education Master's of Science · University of Lucknow
Location Mumbai, Maharashtra, India
Current company Indian Institute of Technology, Bombay Profile snapshot · Sep 2026 SA Shirish Arya Co-Founder & Director - Corporate Strategy & Business Development
Highest education MBA · IMDR
Team & hiring signals LinkedIn headcount 193 51-200
LinkedIn followers 37,682
Earlier recorded team 139 2024, a different source
Open roles 1 of 5 tracked · last posted Jun 2026
Jun 2026 Hiring: Receptionist · Navi Mumbai, MaharashtraJun 2026 Hiring: Strategic Accounts Lead · Cambridge, Navi Mumbai, MaharashtraLinkedIn page Recent company signals Jun 2026 Milestone 750+ patients treatedFrom the company’s LinkedIn posts Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹7.42 cr · FY 2024-25
Revenue growth +185% · 2024–2025
Revenue model E-commerce - product, Physical commerce
Team size 75
Recorded funding US$9.83m · Series B · Jun 2024
Founded 2008 · about 18 years old
Stage Series B
Focus In-vitro diagnostic tests, Pan cancer Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹7.42 cr in FY24-25 · net −₹17.26 cr · +8079% since FY2018
Filed standalone accounts · Epigeneres Biotech Private Limited Funding over time Series A · Apr 2018 A '18 Series B · Dec 2021 B '21 Series B · Jun 2024 B '24 US$9.83m across 3 disclosed equity rounds
Darker bars = larger rounds Founders · 1 AT Ashish Tripathi Founder & Chairman
Highest education Master's of business administration in finance · Melbourne Business School
Location Mumbai, Maharashtra, India
Current company Tzar Labs Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 85 51-200
LinkedIn followers 5,100
Earlier recorded team 75 2024, a different source
Open roles 2 of 3 tracked · last posted May 2026
May 2026 Hiring: Junior Legal ExecutiveApr 2026 Hiring: Clinical Oncology LiaisonApr 2026 Hiring: Business Development Manager · Mumbai, Bengaluru, New DelhiLinkedIn page Technology React Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹10.02 cr · FY 2024-25
Revenue growth +40% · 2024–2025
Revenue model Subscription
Team size 19
Recorded funding US$9.00m · Series A · Sep 2017
Founded 2011 · about 15 years old
Stage Series A
Focus In-vitro diagnostic tests, Women's cancer, Breast cancer, Prognosis Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹10.02 cr in FY24-25 · net ₹3.71 cr · +187% since FY2018
Filed standalone accounts · Oncostem Diagnostics Private Limited Funding over time Seed · Jan 2011 Seed '11 Series A · Sep 2017 A '17 US$9.00m across 2 disclosed equity rounds
Darker bars = larger rounds Founders · 1 MB Manjiri Bakre Founder & CEO
Location Bengaluru, Karnataka, India Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 22 11-50
LinkedIn followers 6,955
Earlier recorded team 19 2024, a different source
LinkedIn page Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts Revenue growth ●●●●
Revenue model E-commerce - product, Physical commerce
Team size 38
Recorded funding US$6.99m · Series A · Oct 2016
Founded 2011 · about 15 years old
Stage Series A
Focus Drugs, Diversified Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Invictus Oncology Private Limited Funding over time Series A · Feb 2013 A '13 Series A · May 2014 A '14 Series A · Aug 2015 A '15 Series A · Jun 2016 A '16 Series A · Oct 2016 A '16 US$6.99m across 5 disclosed equity rounds
Darker bars = larger rounds Founders · 1 RM Raghunath Mashelkar Co-Founder
Team & hiring signals LinkedIn headcount 16 2-10
LinkedIn followers 523
Earlier recorded team 38 2019, a different source
LinkedIn page Patents Patent filings 51
Focus: Lipid‑nanoparticle delivery of platinum chemotherapeutics and signaling‑inhibitor therapeutics
CPC C07F15/0093, A61K31/337, A61K47/60 Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue Not reported
Revenue growth Not reported
Revenue model Fee-for-service
Team size Not available
Recorded funding US$4.69m · Series A · May 2026
Founded 2021 · about 5 years old
Stage Series A
Focus Drugs, Diversified Revenue over time FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹46.11 lakh in FY24-25 · net −₹83.74 lakh · +2206% since FY2022
Filed standalone accounts · Cellogen Therapeutics Private Limited (matched by legal name) Funding over time Seed · Jan 2024 Seed '24 Seed · Apr 2025 Seed '25 Series A · May 2026 A '26 US$4.69m across 3 disclosed equity rounds
Darker bars = larger rounds Patents Patent filings 6
Focus: CAR T-cell therapies targeting B‑cell malignancies
CPC C07K14/7051 Technology Cloudflare Tailwind CSS Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹2.83 cr · FY 2018-19
Revenue growth -18% · 2018–2019
Revenue model Fee-for-service
Team size 3
Recorded funding US$4.40m · Series A · Sep 2013
Founded 2013 · about 13 years old
Stage Series A
Focus Drugs, Autoimmune diseases, Diversified Revenue over time FY2014 14 FY2015 15 FY2016 16 FY2017 17 FY2018 18 FY2019 19 ₹2.83 cr in FY18-19 · net −₹34.44 lakh · +166% since FY2014
Filed standalone accounts · Theramyt Novobiologics Private Limited Investors · 5 A KI MG Menaka Gubbi Angel
Patents Patent filings 3
Focus: Manufacturing of exendin‑4 peptide therapeutics
CPC C07K14/57563 Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts Revenue growth ●●●●
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding US$4.20m · Seed · Dec 2024
Founded 2022 · about 4 years old
Stage Seed
Focus Drugs, Diversified Revenue over time FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · East Ocyon Bio Private Limited Founders · 2 NM Narinder Mehra Co-Founder & Director
DK Dinesh Kundu Co-Founder & Director
Highest education MBA · London Business School
Location Gurgaon, Haryana, India Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 35 11-50
LinkedIn followers 1,266
Open roles 0 of 1 tracked · last posted Sep 2025
Sep 2025 Hiring: Research Scientist · FaridabadLinkedIn page Technology React Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts Revenue growth ●●●●
Revenue model Advertising, Commission on transaction, E-commerce - product
Team size 4
Recorded funding US$2.57m · Seed · Apr 2025
Founded 2021 · about 5 years old
Stage Seed
Focus In-vitro diagnostic tests, Gastrointestinal cancer, Liver cancer, In vitro diagnostic tests Revenue over time FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Tvaster Genkalp Private Limited Funding over time Seed · Sep 2023 Seed '23 Seed · Apr 2025 Seed '25 US$2.57m across 2 disclosed equity rounds
Darker bars = larger rounds Founders · 2 SR Srikar Raman Co-Founder & CEO
Highest education Doctorates in mechanical engineering · University Of Illinois At Chicago
Location Chennai, Tamil Nadu, India
Current company Tvaster Genkalp Profile snapshot · Sep 2026 SK Sreedurgalakshmi K Co-Founder
Highest education Master's of Technology · SRM
Location Chennai, Tamil Nadu, India
Current company Tvaster Genkalp Profile snapshot · Sep 2026 Investors · 4 IS Invigo Softwares Fund
RH Rela Hospitals Fund
MR Mohamed Rela Angel
Patents Patent filings 3
Focus: Epigenetic diagnostic kits detecting carcinomas via methylation markers without sequencing
CPC C12Q1/6886, C12Q1/6858 Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹13.81 lakh · FY 2024-25 Revenue growth ●●●●
Revenue model Subscription
Team size 8
Recorded funding US$2.17m · Seed · Jan 2025
Founded 2019 · about 7 years old
Stage Seed
Focus In-vitro diagnostic tests, Gastrointestinal cancer, Oral cancer Revenue over time FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹13.81 lakh in FY24-25 · net −₹1.30 cr · +3622% since FY2021
Filed standalone accounts · Curo Biosciences Private Limited Funding over time Seed · Sep 2021 Seed '21 Seed · Jun 2023 Seed '23 Seed · Jan 2025 Seed '25 US$2.17m across 3 disclosed equity rounds
Darker bars = larger rounds Founders · 2 DB Deovrat Begde Co-Founder
Highest education Rashtrasant Tukadoji Maharaj Nagpur University
Location Nagpur, Maharashtra, India
Current company CURO BIOSCIENCES PRIVATE LIMITED Profile snapshot · Sep 2026 ST Shubhendra Thakur Co-Founder & CEO
Highest education DACN
Location Nagpur, Maharashtra, India Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 14 11-50
LinkedIn followers 1,044
LinkedIn page Recent company signals Mar 2026 Award Edward Kennedy Memorial Award — 9th World Cancer Congress 2026Feb 2026 Milestone awarded Breakthrough Device Designation - a global recognition of the device potential to transform early oral cancer diagnostics US FDA BreFrom the company’s LinkedIn posts Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Founders and momentum in India Meet the people behind oncology companies in India. 89 of 107 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.
Fastest revenue growth Oncology companies in India with the highest one-year revenue growth among those reporting at least ₹5 crore in revenue. Growth is the reported one-year change for the period shown.
Oncology ImmunoACT Developer of cell and gene therapies for cancer treatment
Revenue growth · 2024–2025 +510% Revenue ₹67.57 cr · FY 2024-25
RP SA Shirish Arya Co-Founder & Director - Corporate Strategy & Business Development
Explore company Oncology Immuneel Developer of T-cell therapies for the treatment of cancer
Revenue growth · 2024–2025 +342% Revenue ₹9.92 cr · FY 2024-25
Founder · 1
SM Explore company Diabetes Sekkei Bio Developer of drugs and vaccines to treat multiple diseases
Revenue growth · 2024–2025 +255% Revenue ₹7.55 cr · FY 2024-25
Founder · 1
MC Explore company Oncology Epigeneres Provider of genomics based diagnostic tests for cancer
Revenue growth · 2024–2025 +185% Revenue ₹7.42 cr · FY 2024-25
Founder · 1
AT Explore company Oncology Perfint Healthcare Developer of solutions for image-guided interventional procedures
Revenue growth · 2024–2025 +45% Revenue ₹10.70 cr · FY 2024-25
Explore company Oncology OncoStem Developer of prognostic tests for the detection of cancer
Revenue growth · 2024–2025 +40% Revenue ₹10.02 cr · FY 2024-25
Explore company Oncology Zuvius Lifesciences Research-based pharmaceutical company specializing in chemotherapeutic formulations and nutraceuticals
Revenue growth · 2023–2024 +38% Revenue ₹39.04 cr · FY 2023-24
Explore company Genomics Datar Genetics Provider of liquid biopsy-based cancer diagnostic test
Revenue growth · 2024–2025 +31% Revenue ₹102.27 cr · FY 2024-25
Explore company Immunotherapy Curadev Pharma Developer of small molecule immunotherapy drugs for cancer and inflammation
Revenue growth · 2024–2025 +24% Revenue ₹14.08 cr · FY 2024-25
Explore company Oncology Beta Drugs Developer of therapeutics for oncology and dermatology
Revenue growth · 2024–2025 +24% Revenue ₹368.79 cr · FY 2024-25
Leadership · 1
RB Rahul Batra Chairman & Managing Director
Explore company Oncology SATYA Pharma Innovations Developer of small molecules for the treatment of cancer
Revenue growth · 2024–2025 +24% Revenue ₹7.55 cr · FY 2024-25
Founder · 1
MC Murthy Chavali Founder & CEO
Explore company Oncology PredOmix Developer of cancer detection blood test
Revenue growth · 2024–2025 +6% Revenue ₹6.98 cr · FY 2024-25
Founder · 1
KR Explore company Business facts
Revenue ₹67.57 cr · FY 2024-25
Revenue growth +510% · 2024–2025
Revenue model Fee-for-service
Team size 139
Recorded funding US$15.87m · Series B · May 2023
Founded 2018 · about 8 years old
Stage Series B
Focus Drugs, Blood cancer Revenue over time FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹67.57 cr in FY24-25 · net ₹10.18 cr · +287274% since FY2021
Filed standalone accounts · Immunoadoptive Cell Therapy Private Limited Funding over time Series A · Nov 2021 A '21 Series B · May 2023 B '23 US$15.87m across 2 disclosed equity rounds
Darker bars = larger rounds Founders · 3 AK Atharva Karulkar Co-Founder
Highest education Doctor of Philosophy · Indian Institute of Technology Bombay
Location Mumbai, Maharashtra, India Profile snapshot · Sep 2026 RP Rahul Purwar Co-Founder & CEO
Highest education Master's of Science · University of Lucknow
Location Mumbai, Maharashtra, India
Current company Indian Institute of Technology, Bombay Profile snapshot · Sep 2026 SA Shirish Arya Co-Founder & Director - Corporate Strategy & Business Development
Highest education MBA · IMDR
Team & hiring signals LinkedIn headcount 193 51-200
LinkedIn followers 37,682
Earlier recorded team 139 2024, a different source
Open roles 1 of 5 tracked · last posted Jun 2026
Jun 2026 Hiring: Receptionist · Navi Mumbai, MaharashtraJun 2026 Hiring: Strategic Accounts Lead · Cambridge, Navi Mumbai, MaharashtraLinkedIn page Recent company signals Jun 2026 Milestone 750+ patients treatedFrom the company’s LinkedIn posts Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹9.92 cr · FY 2024-25
Revenue growth +342% · 2024–2025
Revenue model Fee-for-service
Team size 67 (previous snapshot 50)
Recorded funding US$39.34m · Series A · Jun 2024
Founded 2018 · about 8 years old
Stage Series A
Focus Drugs, Diversified Revenue over time FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹9.92 cr in FY24-25 · net −₹40.46 cr · +1378% since FY2020
Filed standalone accounts · Immuneel Therapeutics Private Limited Funding over time Series A · Nov 2019 A '19 Series A · Sep 2020 A '20 Series A · Apr 2022 A '22 Series A · Jun 2024 A '24 US$39.34m across 4 disclosed equity rounds
Darker bars = larger rounds Founders · 1 SM Siddhartha Mukherjee Co-Founder
Location New York, New York, United States
Current company Columbia University Medical Center Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 112 51-200
LinkedIn followers 73,120
Earlier recorded team 67 2024, a different source
LinkedIn page Recent company signals Jun 2026 Leadership Hired a Associate Director – Global Market AccessFrom the company’s LinkedIn posts Technology PHP MySQL Salesforce WordPress Bootstrap Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹7.55 cr · FY 2024-25
Revenue growth +255% · 2024–2025
Revenue model Fee-for-service
Team size Not available
Recorded funding US$2.03m · Seed · Feb 2021
Founded 2017 · about 9 years old
Stage Series A
Focus Drugs, Diversified, Viral Revenue over time FY2019 19 FY2020 20 FY2021: no filing on record 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹7.55 cr in FY24-25 · net −₹1.96 cr · +6190% since FY2019
Filed standalone accounts · Sekkei Bio Private Limited Funding over time Series A · Jan 2021 A '21 Seed · Feb 2021 Seed '21 US$2.03m across 2 disclosed equity rounds
Darker bars = larger rounds Founders · 1 MC Monalisa Chatterji Co-Founder
Highest education MSc · Indian Institute of Science
Location Bangalore Urban, Karnataka, India
Current company Sekkei Bio Private Limited Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 22 11-50
LinkedIn followers 2,736
Open roles 1 of 2 tracked · last posted Apr 2026
Apr 2026 Hiring: Upstream ScientistApr 2026 Hiring: Project Lead · Bangalore, IndiaLinkedIn page Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹7.42 cr · FY 2024-25
Revenue growth +185% · 2024–2025
Revenue model E-commerce - product, Physical commerce
Team size 75
Recorded funding US$9.83m · Series B · Jun 2024
Founded 2008 · about 18 years old
Stage Series B
Focus In-vitro diagnostic tests, Pan cancer Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹7.42 cr in FY24-25 · net −₹17.26 cr · +8079% since FY2018
Filed standalone accounts · Epigeneres Biotech Private Limited Funding over time Series A · Apr 2018 A '18 Series B · Dec 2021 B '21 Series B · Jun 2024 B '24 US$9.83m across 3 disclosed equity rounds
Darker bars = larger rounds Founders · 1 AT Ashish Tripathi Founder & Chairman
Highest education Master's of business administration in finance · Melbourne Business School
Location Mumbai, Maharashtra, India
Current company Tzar Labs Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 85 51-200
LinkedIn followers 5,100
Earlier recorded team 75 2024, a different source
Open roles 2 of 3 tracked · last posted May 2026
May 2026 Hiring: Junior Legal ExecutiveApr 2026 Hiring: Clinical Oncology LiaisonApr 2026 Hiring: Business Development Manager · Mumbai, Bengaluru, New DelhiLinkedIn page Technology React Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹10.70 cr · FY 2024-25
Revenue growth +45% · 2024–2025
Revenue model E-commerce - product, Physical commerce
Team size 31 (previous snapshot 201)
Recorded funding US$41.48m · Series D · Apr 2017
Founded 2005 · about 21 years old
Stage Series D
Focus Medical devices, Imaging, Diversified, Computerized tomography Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹10.70 cr in FY24-25 · net ₹1.26 cr · -29% since FY2018
Filed standalone accounts · Perfint Healthcare Private Limited Funding over time Series A · Nov 2009 A '09 Series A · Mar 2010 A '10 Series B · Jun 2010 B '10 Series C · Dec 2011 C '11 Series C · Mar 2012 C '12 Series D · Jan 2013 D '13 Series D · Jan 2015 D '15 Series D · Jun 2016 D '16 Series D · Apr 2017 D '17 US$41.48m across 10 disclosed equity rounds
Darker bars = larger rounds Founders · 2 GK Gopalkrishna Kulkarni ex-Co-Founder
Highest education Pgdbm · ERNET India
Location Bengaluru, Karnataka, India Profile snapshot · Sep 2026 NS Nandakumar Subburaman Co-Founder & CEO
Investors · 4 A EV Erasmic Venture Fund Fund
Team & hiring signals LinkedIn headcount 150 51-200
LinkedIn followers 13,468
Earlier recorded team 31 2024, a different source
Open roles 3 of 7 tracked · last posted Aug 2026
May 2026 Hiring: Junior Stores Executive · ChennaiMay 2026 Hiring: CSR FacilitatorMay 2026 Internship: Sales InternLinkedIn page Patents Patent filings 28
Focus: Robotic and sensor‑guided needle positioning for image‑guided minimally invasive procedures
CPC A61B34/10, A61B17/3403, A61B5/0084 Technology Cloudflare Bootstrap jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹10.02 cr · FY 2024-25
Revenue growth +40% · 2024–2025
Revenue model Subscription
Team size 19
Recorded funding US$9.00m · Series A · Sep 2017
Founded 2011 · about 15 years old
Stage Series A
Focus In-vitro diagnostic tests, Women's cancer, Breast cancer, Prognosis Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹10.02 cr in FY24-25 · net ₹3.71 cr · +187% since FY2018
Filed standalone accounts · Oncostem Diagnostics Private Limited Funding over time Seed · Jan 2011 Seed '11 Series A · Sep 2017 A '17 US$9.00m across 2 disclosed equity rounds
Darker bars = larger rounds Founders · 1 MB Manjiri Bakre Founder & CEO
Location Bengaluru, Karnataka, India Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 22 11-50
LinkedIn followers 6,955
Earlier recorded team 19 2024, a different source
LinkedIn page Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹39.04 cr · FY 2023-24
Revenue growth +38% · 2023–2024
Revenue model E-commerce - product, Physical commerce
Team size 36
Recorded funding None recorded
Founded 2005 · about 21 years old
Stage Unfunded
Focus Dietary supplements, Disease specific, Cancer, Drugs Revenue over time FY2017 17 FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 ₹39.04 cr in FY23-24 · net ₹1.85 cr · +200% since FY2017
Filed standalone accounts · Zuvius Lifesciences Private Limited Founders · 2
Location Mumbai, Maharashtra, India
Current company Zuvius Lifesciences Pvt. Ltd. Profile snapshot · Sep 2026 NT Nimish Thakkar Co-Founder & CEO
Team & hiring signals LinkedIn headcount 64 51-200
LinkedIn followers 2,872
Earlier recorded team 36 2024, a different source
LinkedIn page Technology PHP MySQL Cloudflare WordPress Bootstrap Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹102.27 cr · FY 2024-25
Revenue growth +31% · 2024–2025
Revenue model Fee-for-service
Team size 175 (previous snapshot 60)
Recorded funding None recorded
Founded 1992 · about 34 years old
Stage Early Stage
Focus Applied genomics, Clinical genomics, Diagnostics, Sequencing-based Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹26.76 cr in FY24-25 · net −₹8.02 cr · +315% since FY2018
Filed standalone accounts · Datar Cancer Genetics Private Limited Founders · 1
Highest education Savitribai Phule Pune University
Location Nasik, Maharashtra, India
Current company Datar Cancer Genetics Limited Profile snapshot · Sep 2026 Technology Cloudflare Bootstrap jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹14.08 cr · FY 2024-25
Revenue growth +24% · 2024–2025
Revenue model Fee-for-service
Team size 38 (previous snapshot 40)
Recorded funding US$881k · Angel · Mar 2011
Founded 2010 · about 16 years old
Stage Seed
Focus Drugs, Diversified Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹14.08 cr in FY24-25 · net −₹20.93 cr · +580% since FY2018
Filed standalone accounts · Curadev Pharma Private Limited Founders · 2
Highest education MS · Indian Institute of Technology Kanpur
MT Manish Tandon Director and Co-Founder
Highest education Wharton Executive Education
Location Boston, Massachusetts, United States
Current company CURADEV PHARMA Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 42 51-200
LinkedIn followers 9,006
Earlier recorded team 38 2024, a different source
Open roles 3 of 4 tracked · last posted Jul 2026
Jun 2026 Hiring: Research Biologist · Noida, Uttar PradeshJun 2026 Hiring: Laboratory Technician · Noida, Uttar Pradesh, IndiaMay 2026 Hiring: Clinical Trial Assistant (CTA) · Noida / New DelhiLinkedIn page Patents Patent filings 87
Focus: Small‑molecule STING antagonists and ACSS2 inhibitors for immuno‑oncology therapy
CPC C07D333/66, C07D417/12, C08B37/0012 Technology Google Cloud React Sentry Bootstrap Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹368.79 cr · FY 2024-25
Revenue growth +24% · 2024–2025
Revenue model E-commerce - product, Physical commerce
Team size 380
Recorded funding None recorded
Founded 2005 · about 21 years old
Stage Public
Focus Diversified, Small molecules & peptides, Drugs Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹226.39 cr in FY24-25 · net ₹15.43 cr · +346% since FY2018
Filed standalone accounts · Beta Drugs Limited Leadership · 1 RB Rahul Batra Chairman & Managing Director
Team & hiring signals LinkedIn headcount 266 51-200
LinkedIn followers 5,682
Earlier recorded team 380 2024, a different source
LinkedIn page Technology PHP MySQL Cloudflare WordPress Bootstrap Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹7.55 cr · FY 2024-25
Revenue growth +24% · 2024–2025
Revenue model Physical commerce
Team size 38
Recorded funding None recorded
Founded 2019 · about 7 years old
Stage Unfunded
Focus Drugs, Diversified Revenue growth Latest revenue ₹7.55 cr FY 2024-25
1y growth +24%
3y growth +298%
5y growth -2%
Reported compound annual growth Founders · 1 MC Murthy Chavali Founder & CEO
Team & hiring signals LinkedIn headcount 41 11-50
LinkedIn followers 3,104
Earlier recorded team 38 2024, a different source
Open roles 0 of 1 tracked · last posted Sep 2025
Sep 2025 Hiring: AccountantLinkedIn page Technology PHP Cloudflare Bootstrap jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹6.98 cr · FY 2024-25
Revenue growth +6% · 2024–2025
Revenue model Subscription
Team size 17
Recorded funding US$662k · Seed · Jun 2019
Founded 2018 · about 8 years old
Stage Seed
Focus In-vitro diagnostic tests, Diversified Revenue over time FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹6.98 cr in FY24-25 · net −₹8.41 lakh · +139% since FY2021
Filed standalone accounts · Predomix Technologies Private Limited Founders · 1 KR Kanury Rao Co-Founder
Highest education Savitribai Phule Pune University
Location Gurgaon, Haryana, India
Current company PredOmix Technologies Pvt. Ltd. Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 9 2-10
LinkedIn followers 535
Earlier recorded team 17 2024, a different source
LinkedIn page Technology PHP Cloudflare Bootstrap jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Women-founded Oncology companies in India with at least one woman on the founding team. Expand a profile to meet the founders; teams can include both women and men.
Genomics Positive Bioscience Provider of DNA tests for cancer treatment & hereditary cancer screening
SJ BJ Explore company Oncology BioMarkIQ Developer of in-vitro diagnostic platform for cancer
Explore company Immunotherapy Zumutor Developer of novel immunotherapy and monoclonal antibody therapeutics
Revenue ₹4.63 cr FY 2024-25
KI Explore company Life sciences platforms and tools Mestastop Developer of cell-based functional assays for cancer metastasis focused drug discovery and predictive diagnostics
DC AC Explore company Oncology Tvaster Genkalp Developer of epigenetic-based liquid biopsy tests for cancer detection. This company provides molecular diagnostic solutions focusing on identifying genetic and epigenetic modifications to aid oncologists in making informed treatment decisions. The tests utilize a minimally invasive blood sample to diagnose and understand genetic and epigenetic alterations, enabling personalized healthcare decisions. The technology combines epigenetics, liquid biopsy, and digital droplet PCR for efficient cancer screening. The company's mission is to provide clinically relevant information to improve the quali
SR SK Explore company Oncology Exsure Developer of nano drug delivery platform for cancer treatment
Revenue ₹7.44 lakh FY 2024-25
SP AD Explore company Oncology MagHeals Provider of magnetic hyperthermia therapy device to treat cancer
RK SJ Explore company Diabetes BioGenomics Developer of recombinant DNA-based biosimilars, recombinant proteins, and enzymes
Revenue ₹10.70 cr FY 2022-23
Founder · 1
SS Explore company Oncology Sāscan Developer of screening devices for the detection of cancer
Explore company Oncology East Ocyon Bio Developer of cell and gene therapies for the treatment of cancer
NM Narinder Mehra Co-Founder & Director
Explore company Diabetes Sekkei Bio Developer of drugs and vaccines to treat multiple diseases
Revenue ₹7.55 cr FY 2024-25
Founder · 1
MC Explore company Oncology Zuvius Lifesciences Research-based pharmaceutical company specializing in chemotherapeutic formulations and nutraceuticals
Revenue ₹39.04 cr FY 2023-24
Explore company Business facts Revenue growth ●●●●
Revenue model Subscription
Team size 11 (previous snapshot 31)
Recorded funding US$466k · Angel · Nov 2018
Founded 2012 · about 14 years old
Stage Seed
Focus In-vitro diagnostic tests, Diversified, Enabling technologies, Kits and reagents Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Positive Biosciences Limited Founders · 3 SJ Samarth Jain Co-Founder & CEO
Highest education MIT Professional Education
Location Mumbai, Maharashtra, India
Current company Positive Bioscience Profile snapshot · Sep 2026 BJ Bapsy Jain Co-Founder & CFO
Location Mumbai, Maharashtra, India
Current company S P Jain School of Global Management Profile snapshot · Sep 2026 MM Meetha Medhora Co-Founder
Highest education Genetics · Washington University In St. Louis
Location Brookfield, Wisconsin, United States Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 14 11-50
LinkedIn followers 3,736
Earlier recorded team 11 2023, a different source
LinkedIn page Technology PHP MySQL Nginx WordPress jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts Revenue growth ●●●●
Revenue model Subscription
Team size Not available
Recorded funding None recorded
Founded 2023 · about 3 years old
Stage Funding Raised
Focus In-vitro diagnostic tests, Lung cancer Revenue growth Latest revenue ●●●● FY 2024-25 Reported compound annual growth Founders · 3 MK Manasi Kulkarni-Khasnis Co-Founder & CEO
Highest education PhD · IISER
Location Pune, Maharashtra, India
Current company BioMarkIQ Profile snapshot · Sep 2026 SS Snahlata Singh Co-Founder & CSO
Highest education Bachelor's of Science · Hindu College
Location Pune Division, Maharashtra, India
Current company Indian Women Scientists' Association Profile snapshot · Sep 2026 AJ Atharva Joshi Co-Founder & CTO
Highest education BTech · Vishwakarma University
Location Pune, Maharashtra, India
Current company BioMarkIQ Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 15 2-10
LinkedIn followers 4,090
Open roles 2 of 5 tracked · last posted Apr 2026
Apr 2026 Hiring: Founder's Office AssociateOct 2025 Internship: Clinical Collaboration & Outreach Intern · PuneOct 2025 Internship: Biomarker Discovery & Analysis Intern · PuneLinkedIn page Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹4.63 cr · FY 2024-25
Revenue growth -64% · 2024–2025
Revenue model Fee-for-service
Team size 24 (previous snapshot 37)
Recorded funding US$27.89m · Series A · Nov 2024
Founded 2013 · about 13 years old
Stage Series A
Focus Drugs, Diversified, Immuno oncology Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹4.63 cr in FY24-25 · net −₹3.90 cr · -52% since FY2018
Filed standalone accounts · Zumutor Biologics Private Limited Funding over time Seed · Jan 2013 Seed '13 Series A · Jan 2015 A '15 Series A · Apr 2018 A '18 Series A · Nov 2019 A '19 Series A · Aug 2021 A '21 Series A · Oct 2022 A '22 Series A · Feb 2024 A '24 Series A · Nov 2024 A '24 US$27.89m across 8 disclosed equity rounds
Darker bars = larger rounds Founders · 2 KI Kavitha Iyer Rodrigues Co-Founder & CEO
Highest education Master's of Business Administration, Management · Indian Institute of Management Bangalore
Location Greater Bengaluru Area
Current company Zumutor Biologics Inc. Profile snapshot · Sep 2026
Highest education Wright State University Boonshoft School Of Medicine
Location Bengaluru, Karnataka, India
Current company Zumutor Biologics Inc. Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 25 11-50
LinkedIn followers 8,561
Earlier recorded team 24 2023, a different source
LinkedIn page Technology PHP MySQL Cloudflare WordPress Bootstrap Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts Revenue growth ●●●●
Revenue model Fee-for-service
Team size 12
Recorded funding US$1.29m · Seed · May 2024
Founded 2018 · about 8 years old
Stage Seed
Focus Research assays, Drug discovery, Organoid models, Patient derived cancer cell models Revenue over time FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Mestastop Solutions Private Limited Funding over time Angel · Jul 2020 Angel '20 Seed · Dec 2020 Seed '20 Seed · Aug 2023 Seed '23 Seed · Dec 2023 Seed '23 Seed · May 2024 Seed '24 US$1.29m across 5 disclosed equity rounds
Darker bars = larger rounds Founders · 2 DC Debabani Chowdhury Co-Founder
Highest education Manimala Girls' High School
Location Bengaluru, Karnataka, India
Current company Mestastop Solutions Profile snapshot · Sep 2026 AC Arnab Chowdhury Co-Founder
Location Bengaluru, Karnataka, India
Current company Mestastop Solutions Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 23 11-50
LinkedIn followers 2,832
LinkedIn page Recent company signals Jan 2026 Milestone 67% of journey completed, another 3 years milestoneFrom the company’s LinkedIn posts Patents Patent filings 9
Focus: AI-based cancer metastasis prediction platforms and repurposed drug screening for metastasis inhibition
CPC G16H50/20, A61P35/00, A61P35/04 Technology PHP MySQL Cloudflare WordPress Bootstrap Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts Revenue growth ●●●●
Revenue model Advertising, Commission on transaction, E-commerce - product
Team size 4
Recorded funding US$2.57m · Seed · Apr 2025
Founded 2021 · about 5 years old
Stage Seed
Focus In-vitro diagnostic tests, Gastrointestinal cancer, Liver cancer, In vitro diagnostic tests Revenue over time FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Tvaster Genkalp Private Limited Funding over time Seed · Sep 2023 Seed '23 Seed · Apr 2025 Seed '25 US$2.57m across 2 disclosed equity rounds
Darker bars = larger rounds Founders · 2 SR Srikar Raman Co-Founder & CEO
Highest education Doctorates in mechanical engineering · University Of Illinois At Chicago
Location Chennai, Tamil Nadu, India
Current company Tvaster Genkalp Profile snapshot · Sep 2026 SK Sreedurgalakshmi K Co-Founder
Highest education Master's of Technology · SRM
Location Chennai, Tamil Nadu, India
Current company Tvaster Genkalp Profile snapshot · Sep 2026 Investors · 4 IS Invigo Softwares Fund
RH Rela Hospitals Fund
MR Mohamed Rela Angel
Patents Patent filings 3
Focus: Epigenetic diagnostic kits detecting carcinomas via methylation markers without sequencing
CPC C12Q1/6886, C12Q1/6858 Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹7.44 lakh · FY 2024-25
Revenue growth -74% · 2024–2025
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding US$358k · Seed · Oct 2025
Founded 2021 · about 5 years old
Stage Seed
Focus Drugs, Diversified, Nanoparticle based, Encapsulation Revenue over time FY2023 23 FY2024 24 FY2025 25 ₹7.44 lakh in FY24-25 · net ●●●● ●●●●
Filed standalone accounts · Exsure Private Limited Funding over time Seed · Jan 2025 Seed '25 Seed · Oct 2025 Seed '25 US$358k across 2 disclosed equity rounds
Darker bars = larger rounds Founders · 2 SP Swastika Paul Co-Founder
Highest education St. Xavier's College (Autonomous), Kolkata
Location West Bengal, India
Current company Okinawa Institute of Science and Technology Profile snapshot · Sep 2026 AD Abhishek Dutta Co-Founder & CEO
Highest education St. Xavier's College
Location India
Current company Cancer Biology and Therapy Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 7 2-10
LinkedIn followers 2,210
Open roles 1 of 1 tracked · last posted May 2026
LinkedIn page Technology PHP MySQL WordPress Bootstrap jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue growth -76% · 2024–2025
Revenue model Fee-for-service
Team size Not available
Recorded funding None recorded
Founded 2021 · about 5 years old
Stage Funding Raised
Focus Medical devices, Therapies, Radiation therapy, Thermal therapy Revenue over time FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●●
Filed standalone accounts · Magheals Private Limited Founders · 2 RK Rajesh Katoch Co-Founder and Director
Location Bengaluru, Karnataka, India
Current company MagHeals Private Limited Profile snapshot · Sep 2026 SJ Shilpee Jain Co-Founder
Highest education Indian Institute of Technology Kanpur
Location Bengaluru, Karnataka, India
Current company Chanakya University Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 3 2-10
LinkedIn followers 294
Open roles 1 of 1 tracked · last posted Jun 2026
Jun 2026 Hiring: Project Technical Support - III · MagHeals Pvt Ltd, BangaloreLinkedIn page Recent company signals Jan 2026 Award ELEVATE 2025 award — IT BT DepartmentFrom the company’s LinkedIn posts Patents Patent filings 2
Focus: Therapeutic high‑frequency magnetic induction devices for oral cancer treatment
CPC A61N2/02 Technology Bootstrap jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹10.70 cr · FY 2022-23
Revenue growth Not reported
Revenue model Physical commerce
Team size 136
Recorded funding US$24.62m · Seed · Jul 2022
Founded 2002 · about 24 years old
Stage Seed
Focus Drugs, Diversified Revenue over time FY2016 16 FY2017 17 FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 ₹10.70 cr in FY22-23 · net −₹30.77 cr · +206% since FY2016
Filed standalone accounts · Biogenomics Limited Founders · 1 SS Sanjay Sonar Co-Founder & Owner & President & CEO
Highest education IIT Bombay
Location Thane, Maharashtra, India
Current company BioGenomics Limited Profile snapshot · Sep 2026 Investors · 2 EA Eagle Asia Holding Fund
Team & hiring signals LinkedIn headcount 288 201-500
LinkedIn followers 23,784
Earlier recorded team 136 2024, a different source
Open roles 1 of 2 tracked · last posted Mar 2026
LinkedIn page Patents Patent filings 34
Focus: Recombinant protein expression systems and insulin/analog production technologies
CPC C07K1/1136, C07K14/62, C12N15/70 Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue growth Not reported
Revenue model Subscription
Team size 16
Recorded funding US$339k · Seed · Apr 2021
Founded 2015 · about 11 years old
Stage Seed
Focus Medical devices, Imaging, Diversified Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Sascan Meditech Private Limited Funding over time Seed · May 2018 Seed '18 Seed · May 2020 Seed '20 Seed · Apr 2021 Seed '21 US$339k across 3 disclosed equity rounds
Darker bars = larger rounds Founders · 1 SN Subhash Narayanan Founder and CEO
Highest education Doctorates in physics · Cochin University Of Science & Technology, Kochi
Location Thiruvananthapuram, Kerala, India
Current company Sascan Meditech Pvt. Ltd. Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 20 11-50
LinkedIn followers 1,948
Open roles 1 of 1 tracked · last posted May 2026
May 2026 Hiring: Software Developer · ThiruvananthapuramLinkedIn page Recent company signals Jun 2026 Award Indian Patent for Non-invasive multispectral imaging camera for cervical cancer detection — Indian Council of Medical ResearchFrom the company’s LinkedIn posts Technology PHP MySQL Cloudflare WordPress jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts Revenue growth ●●●●
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding US$4.20m · Seed · Dec 2024
Founded 2022 · about 4 years old
Stage Seed
Focus Drugs, Diversified Revenue over time FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · East Ocyon Bio Private Limited Founders · 2 NM Narinder Mehra Co-Founder & Director
DK Dinesh Kundu Co-Founder & Director
Highest education MBA · London Business School
Location Gurgaon, Haryana, India Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 35 11-50
LinkedIn followers 1,266
Open roles 0 of 1 tracked · last posted Sep 2025
Sep 2025 Hiring: Research Scientist · FaridabadLinkedIn page Technology React Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹7.55 cr · FY 2024-25
Revenue growth +255% · 2024–2025
Revenue model Fee-for-service
Team size Not available
Recorded funding US$2.03m · Seed · Feb 2021
Founded 2017 · about 9 years old
Stage Series A
Focus Drugs, Diversified, Viral Revenue over time FY2019 19 FY2020 20 FY2021: no filing on record 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹7.55 cr in FY24-25 · net −₹1.96 cr · +6190% since FY2019
Filed standalone accounts · Sekkei Bio Private Limited Funding over time Series A · Jan 2021 A '21 Seed · Feb 2021 Seed '21 US$2.03m across 2 disclosed equity rounds
Darker bars = larger rounds Founders · 1 MC Monalisa Chatterji Co-Founder
Highest education MSc · Indian Institute of Science
Location Bangalore Urban, Karnataka, India
Current company Sekkei Bio Private Limited Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 22 11-50
LinkedIn followers 2,736
Open roles 1 of 2 tracked · last posted Apr 2026
Apr 2026 Hiring: Upstream ScientistApr 2026 Hiring: Project Lead · Bangalore, IndiaLinkedIn page Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹39.04 cr · FY 2023-24
Revenue growth +38% · 2023–2024
Revenue model E-commerce - product, Physical commerce
Team size 36
Recorded funding None recorded
Founded 2005 · about 21 years old
Stage Unfunded
Focus Dietary supplements, Disease specific, Cancer, Drugs Revenue over time FY2017 17 FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 ₹39.04 cr in FY23-24 · net ₹1.85 cr · +200% since FY2017
Filed standalone accounts · Zuvius Lifesciences Private Limited Founders · 2
Location Mumbai, Maharashtra, India
Current company Zuvius Lifesciences Pvt. Ltd. Profile snapshot · Sep 2026 NT Nimish Thakkar Co-Founder & CEO
Team & hiring signals LinkedIn headcount 64 51-200
LinkedIn followers 2,872
Earlier recorded team 36 2024, a different source
LinkedIn page Technology PHP MySQL Cloudflare WordPress Bootstrap Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Recently founded Oncology companies in India founded in the last four years, newest first.
Oncology Biosysion Developer of diagnostic solutions for early detection of critical diseases
Founded 2025 Unfunded
Explore company Oncology Genoscope Developer of saliva-based diagnostic tests for head and neck cancer
Founded 2024 Unfunded
DM Dushyant Mandlik Co-Founder
VT Vivek Tanavde Co-Founder
KP Kaustubh Patel Co-Founder
SP Shanaya Patel Co-Founder
Explore company Oncology TanPrish Dynamics AI-powered mobile application designed to facilitate early and accurate detection of cervical cancer
Founded 2024 Unfunded
AP AD Explore company Oncology RyGen Biopharma Developer of targeted biologics for rheumatoid arthritis, cancer, and obesity
Founded 2024 Unfunded
Founder · 1
TC Explore company Oncology Cartogene Provider of personalized CAR-T cell therapies, a pioneering approach in cancer treatment leveraging a patient's own immune system to combat blood cancer and other diseases
Founded 2024 Unfunded
Explore company Oncology BioMarkIQ Developer of in-vitro diagnostic platform for cancer
Founded 2023 Funding Raised
Explore company Oncology Medidect Provider of multi-tumor screening blood test for asymptomatic healthy individuals
Founded 2023 Unfunded
Founder · 1
GS Explore company Oncology East Ocyon Bio Developer of cell and gene therapies for the treatment of cancer
Founded 2022 Seed
NM Narinder Mehra Co-Founder & Director
Explore company Immunology Lextro Labs Provider of biotherapeutics for immunological disorders
Founded 2022 Unfunded
AC Akkina Chowdary Co-Founder & Managing Director
Explore company Oncology OncoCheck Developer of medical products for early cancer detection
Founded 2022 Unfunded
Explore company Oncology Smole Biopharma Developer of biopharmaceuticals for cancer treatment
Founded 2022 Unfunded
Founder · 1
SM Sakkarapalayam Mahalingam Founder
Explore company Oncology Kashmirbiotech Developer of a functional food for prostate cancer risk reduction
Founded 2022 Unfunded
Founders
Details not available
Explore company Business facts
Revenue Not reported
Revenue growth Not reported
Revenue model Fee-for-service
Team size Not available
Recorded funding None recorded
Founded 2025 · about 1 years old
Stage Unfunded
Focus Diversified, In-vitro diagnostic tests Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹14.13 lakh · FY 2024-25
Revenue growth Not reported
Revenue model Subscription
Team size Not available
Recorded funding None recorded
Founded 2024 · about 2 years old
Stage Unfunded
Focus Diversified, In-vitro diagnostic tests Founders · 5 DM Dushyant Mandlik Co-Founder
VT Vivek Tanavde Co-Founder
KP Kaustubh Patel Co-Founder
SP Shanaya Patel Co-Founder
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue Not reported
Revenue growth Not reported
Revenue model Subscription
Team size Not available
Recorded funding None recorded
Founded 2024 · about 2 years old
Stage Unfunded
Focus Cervical cancer, In-vitro diagnostic tests Founders · 2 AP Anamika Pandey Co-Founder & CEO
Highest education Bharati Vidyapeeth
Location Kanpur, Uttar Pradesh, India
Current company TanPrish Dynamics Private Limited Profile snapshot · Sep 2026 AD Abhay Dwivedi Co-Founder, CTO & Director
Location Kanpur, Uttar Pradesh, India
Current company TanPrish Dynamics Private Limited Profile snapshot · Sep 2026 Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue Not reported
Revenue growth Not reported
Revenue model Physical commerce
Team size Not available
Recorded funding None recorded
Founded 2024 · about 2 years old
Stage Unfunded
Focus Autoimmune diseases, Diversified, Drugs Founders · 1 TC Tulasi C Co-Founder
Location Greater Hyderabad Area
Current company RYGEN BIOPHARMA PVT LTD Profile snapshot · Sep 2026 Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue Not reported
Revenue growth Not reported
Revenue model Fee-for-service
Team size Not available
Recorded funding None recorded
Founded 2024 · about 2 years old
Stage Unfunded
Focus Diversified, Drugs Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts Revenue growth ●●●●
Revenue model Subscription
Team size Not available
Recorded funding None recorded
Founded 2023 · about 3 years old
Stage Funding Raised
Focus In-vitro diagnostic tests, Lung cancer Revenue growth Latest revenue ●●●● FY 2024-25 Reported compound annual growth Founders · 3 MK Manasi Kulkarni-Khasnis Co-Founder & CEO
Highest education PhD · IISER
Location Pune, Maharashtra, India
Current company BioMarkIQ Profile snapshot · Sep 2026 SS Snahlata Singh Co-Founder & CSO
Highest education Bachelor's of Science · Hindu College
Location Pune Division, Maharashtra, India
Current company Indian Women Scientists' Association Profile snapshot · Sep 2026 AJ Atharva Joshi Co-Founder & CTO
Highest education BTech · Vishwakarma University
Location Pune, Maharashtra, India
Current company BioMarkIQ Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 15 2-10
LinkedIn followers 4,090
Open roles 2 of 5 tracked · last posted Apr 2026
Apr 2026 Hiring: Founder's Office AssociateOct 2025 Internship: Clinical Collaboration & Outreach Intern · PuneOct 2025 Internship: Biomarker Discovery & Analysis Intern · PuneLinkedIn page Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue Not reported
Revenue growth Not reported
Revenue model Subscription
Team size Not available
Recorded funding None recorded
Founded 2023 · about 3 years old
Stage Unfunded
Focus Diversified, In-vitro diagnostic tests Founders · 1 GS Gagandeep Singh Bedi Co-Founder & Director
Highest education The Institute of Chartered Accountants of India
Location Gurugram, Haryana, India
Current company Medidect India Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 7 11-50
LinkedIn followers 86
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts Revenue growth ●●●●
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding US$4.20m · Seed · Dec 2024
Founded 2022 · about 4 years old
Stage Seed
Focus Drugs, Diversified Revenue over time FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · East Ocyon Bio Private Limited Founders · 2 NM Narinder Mehra Co-Founder & Director
DK Dinesh Kundu Co-Founder & Director
Highest education MBA · London Business School
Location Gurgaon, Haryana, India Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 35 11-50
LinkedIn followers 1,266
Open roles 0 of 1 tracked · last posted Sep 2025
Sep 2025 Hiring: Research Scientist · FaridabadLinkedIn page Technology React Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue Not reported
Revenue growth Not reported
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding None recorded
Founded 2022 · about 4 years old
Stage Unfunded
Focus Drugs, Autoimmune diseases, Diversified Founders · 2 AC Akkina Chowdary Co-Founder & Managing Director
MA Murali Addepalli Co-Founder
Highest education MSc · University of Hyderabad
Location Hyderabad, Telangana, India
Current company SANSHI Bio Solutions Private Limited Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 1 11-50
LinkedIn followers 43
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue Not reported
Revenue growth Not reported
Revenue model Subscription
Team size Not available
Recorded funding None recorded
Founded 2022 · about 4 years old
Stage Unfunded
Focus In-vitro diagnostic tests, Diversified Founders · 2 GJ Garima Jain Co-Founder & CSO
Highest education Doctor of Philosophy · University of Ulm HS Himanshu Sanghi Co-Founder & CEO
Highest education Bachelor's of Engineering · BITS Pilani Team & hiring signals LinkedIn headcount 2 2-10
LinkedIn followers 119
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue Not reported
Revenue growth Not reported
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding None recorded
Founded 2022 · about 4 years old
Stage Unfunded
Focus Drugs, Diversified Founders · 1 SM Sakkarapalayam Mahalingam Founder
Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Consumer Social impact
Close × Business facts
Revenue Not reported
Revenue growth Not reported
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding None recorded
Founded 2022 · about 4 years old
Stage Unfunded
Focus Drugs, Prostate cancer Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Most covered in the news Companies with the most distinct news events in the last 24 months across the business press Fliar tracks.
Oncology 4baseCare Provider of precision oncology solutions, including genomic testing and digital health
News events · last 24 months 30 Across tracked business press
KR Kshitij Rishi Co-Founder & COO
Explore company Oncology Immuneel Developer of T-cell therapies for the treatment of cancer
News events · last 24 months 20 Across tracked business press
Founder · 1
SM Explore company Oncology Access Pharma Developer of products for the treatment and supportive care of cancer
News events · last 24 months 20 Across tracked business press
Founders
Details not available
Explore company Oncology CuraTeQ Biologics Developer of immuno-oncology therapeutics
News events · last 24 months 7 Across tracked business press
Explore company Oncology Exsure Developer of nano drug delivery platform for cancer treatment
News events · last 24 months 5 Across tracked business press
SP AD Explore company Oncology Beta Drugs Developer of therapeutics for oncology and dermatology
News events · last 24 months 5 Across tracked business press
Leadership · 1
RB Rahul Batra Chairman & Managing Director
Explore company Genomics Transgene Biotek Developer of immunotherapies and drug delivery solutions for cancer
News events · last 24 months 5 Across tracked business press
Explore company Oncology Tvaster Genkalp Developer of epigenetic-based liquid biopsy tests for cancer detection. This company provides molecular diagnostic solutions focusing on identifying genetic and epigenetic modifications to aid oncologists in making informed treatment decisions. The tests utilize a minimally invasive blood sample to diagnose and understand genetic and epigenetic alterations, enabling personalized healthcare decisions. The technology combines epigenetics, liquid biopsy, and digital droplet PCR for efficient cancer screening. The company's mission is to provide clinically relevant information to improve the quali
News events · last 24 months 4 Across tracked business press
SR SK Explore company Oncology East Ocyon Bio Developer of cell and gene therapies for the treatment of cancer
News events · last 24 months 3 Across tracked business press
NM Narinder Mehra Co-Founder & Director
Explore company Oncology Erly Sign A platform providing test kits for detecting oral cancer
News events · last 24 months 3 Across tracked business press
DB Explore company Ophthalmology Lamark Biotech Developer of thermostable biologics for treating diabetes and other diseases
News events · last 24 months 3 Across tracked business press
Founder · 1
VB Explore company Business facts
Revenue ₹14.27 cr · FY 2024-25
Revenue growth Not reported
Revenue model Subscription
Team size 25
Recorded funding US$22.28m · Series B · Jan 2026
Founded 2018 · about 8 years old
Stage Series B
Focus Applied genomics, Clinical genomics, Diagnostics, Sequencing-based Funding over time Angel · Feb 2019 Angel '19 Seed · Mar 2021 Seed '21 Series A · Jul 2024 A '24 Series A · Dec 2024 A '24 Series A · Nov 2025 A '25 Series B · Jan 2026 B '26 US$22.28m across 6 disclosed equity rounds
Darker bars = larger rounds Founders · 2 HG Hitesh Goswami Co-Founder & CEO
Highest education Sophia College, Mumbai
Location Bengaluru, Karnataka, India
Current company 4baseCare Profile snapshot · Sep 2026 KR Kshitij Rishi Co-Founder & COO
Highest education B.E. · Panjab University
Team & hiring signals LinkedIn headcount 322 51-200
LinkedIn followers 39,764
Open roles 4 of 10 tracked · last posted Jul 2026
LinkedIn page Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹9.92 cr · FY 2024-25
Revenue growth +342% · 2024–2025
Revenue model Fee-for-service
Team size 67 (previous snapshot 50)
Recorded funding US$39.34m · Series A · Jun 2024
Founded 2018 · about 8 years old
Stage Series A
Focus Drugs, Diversified Revenue over time FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹9.92 cr in FY24-25 · net −₹40.46 cr · +1378% since FY2020
Filed standalone accounts · Immuneel Therapeutics Private Limited Funding over time Series A · Nov 2019 A '19 Series A · Sep 2020 A '20 Series A · Apr 2022 A '22 Series A · Jun 2024 A '24 US$39.34m across 4 disclosed equity rounds
Darker bars = larger rounds Founders · 1 SM Siddhartha Mukherjee Co-Founder
Location New York, New York, United States
Current company Columbia University Medical Center Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 112 51-200
LinkedIn followers 73,120
Earlier recorded team 67 2024, a different source
LinkedIn page Recent company signals Jun 2026 Leadership Hired a Associate Director – Global Market AccessFrom the company’s LinkedIn posts Technology PHP MySQL Salesforce WordPress Bootstrap Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Consumer Social impact Software
Close × Business facts
Revenue Not reported
Revenue growth Not reported
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding None recorded
Founded 2005 · about 21 years old
Stage Funding Raised
Focus Diversified, Drugs Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹9.49 cr · FY 2024-25
Revenue growth Not reported
Revenue model E-commerce - product, Physical commerce
Team size 535
Recorded funding None recorded
Founded 2020 · about 6 years old
Stage Unfunded
Focus Drugs, Diversified, Immuno oncology Revenue over time FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹9.49 cr in FY24-25 · net −₹812.07 cr · -81% since FY2021
Filed standalone accounts · Curateq Biologics Private Limited Team & hiring signals LinkedIn headcount 696 501-1,000
LinkedIn followers 19,558
Earlier recorded team 535 2024, a different source
Open roles 0 of 1 tracked · last posted Apr 2025
LinkedIn page Recent company signals Sep 2025 Milestone completed Phase III clinical study completedFrom the company’s LinkedIn posts Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹7.44 lakh · FY 2024-25
Revenue growth -74% · 2024–2025
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding US$358k · Seed · Oct 2025
Founded 2021 · about 5 years old
Stage Seed
Focus Drugs, Diversified, Nanoparticle based, Encapsulation Revenue over time FY2023 23 FY2024 24 FY2025 25 ₹7.44 lakh in FY24-25 · net ●●●● ●●●●
Filed standalone accounts · Exsure Private Limited Funding over time Seed · Jan 2025 Seed '25 Seed · Oct 2025 Seed '25 US$358k across 2 disclosed equity rounds
Darker bars = larger rounds Founders · 2 SP Swastika Paul Co-Founder
Highest education St. Xavier's College (Autonomous), Kolkata
Location West Bengal, India
Current company Okinawa Institute of Science and Technology Profile snapshot · Sep 2026 AD Abhishek Dutta Co-Founder & CEO
Highest education St. Xavier's College
Location India
Current company Cancer Biology and Therapy Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 7 2-10
LinkedIn followers 2,210
Open roles 1 of 1 tracked · last posted May 2026
LinkedIn page Technology PHP MySQL WordPress Bootstrap jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹368.79 cr · FY 2024-25
Revenue growth +24% · 2024–2025
Revenue model E-commerce - product, Physical commerce
Team size 380
Recorded funding None recorded
Founded 2005 · about 21 years old
Stage Public
Focus Diversified, Small molecules & peptides, Drugs Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹226.39 cr in FY24-25 · net ₹15.43 cr · +346% since FY2018
Filed standalone accounts · Beta Drugs Limited Leadership · 1 RB Rahul Batra Chairman & Managing Director
Team & hiring signals LinkedIn headcount 266 51-200
LinkedIn followers 5,682
Earlier recorded team 380 2024, a different source
LinkedIn page Technology PHP MySQL Cloudflare WordPress Bootstrap Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts Revenue growth ●●●●
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding None recorded
Founded 1990 · about 36 years old
Stage Public
Focus Applied genomics, Clinical genomics, Therapeutics, Drugs Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Transgene Biotek Limited. Founders · 1 KR Koteswara Rao Founder & Managing Director
Location Hyderabad, Telangana, India
Current company Transgene Biotek Ltd Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 20 51-200
LinkedIn followers 510
LinkedIn page Patents Patent filings 25
Focus: Advanced oral and nasal peptide drug delivery formulations for insulin and biologics
CPC A61K47/36, A61K38/28, C07K7/08 Technology Cloudflare Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts Revenue growth ●●●●
Revenue model Advertising, Commission on transaction, E-commerce - product
Team size 4
Recorded funding US$2.57m · Seed · Apr 2025
Founded 2021 · about 5 years old
Stage Seed
Focus In-vitro diagnostic tests, Gastrointestinal cancer, Liver cancer, In vitro diagnostic tests Revenue over time FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Tvaster Genkalp Private Limited Funding over time Seed · Sep 2023 Seed '23 Seed · Apr 2025 Seed '25 US$2.57m across 2 disclosed equity rounds
Darker bars = larger rounds Founders · 2 SR Srikar Raman Co-Founder & CEO
Highest education Doctorates in mechanical engineering · University Of Illinois At Chicago
Location Chennai, Tamil Nadu, India
Current company Tvaster Genkalp Profile snapshot · Sep 2026 SK Sreedurgalakshmi K Co-Founder
Highest education Master's of Technology · SRM
Location Chennai, Tamil Nadu, India
Current company Tvaster Genkalp Profile snapshot · Sep 2026 Investors · 4 IS Invigo Softwares Fund
RH Rela Hospitals Fund
MR Mohamed Rela Angel
Patents Patent filings 3
Focus: Epigenetic diagnostic kits detecting carcinomas via methylation markers without sequencing
CPC C12Q1/6886, C12Q1/6858 Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts Revenue growth ●●●●
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding US$4.20m · Seed · Dec 2024
Founded 2022 · about 4 years old
Stage Seed
Focus Drugs, Diversified Revenue over time FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · East Ocyon Bio Private Limited Founders · 2 NM Narinder Mehra Co-Founder & Director
DK Dinesh Kundu Co-Founder & Director
Highest education MBA · London Business School
Location Gurgaon, Haryana, India Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 35 11-50
LinkedIn followers 1,266
Open roles 0 of 1 tracked · last posted Sep 2025
Sep 2025 Hiring: Research Scientist · FaridabadLinkedIn page Technology React Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹13.81 lakh · FY 2024-25 Revenue growth ●●●●
Revenue model Subscription
Team size 8
Recorded funding US$2.17m · Seed · Jan 2025
Founded 2019 · about 7 years old
Stage Seed
Focus In-vitro diagnostic tests, Gastrointestinal cancer, Oral cancer Revenue over time FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹13.81 lakh in FY24-25 · net −₹1.30 cr · +3622% since FY2021
Filed standalone accounts · Curo Biosciences Private Limited Funding over time Seed · Sep 2021 Seed '21 Seed · Jun 2023 Seed '23 Seed · Jan 2025 Seed '25 US$2.17m across 3 disclosed equity rounds
Darker bars = larger rounds Founders · 2 DB Deovrat Begde Co-Founder
Highest education Rashtrasant Tukadoji Maharaj Nagpur University
Location Nagpur, Maharashtra, India
Current company CURO BIOSCIENCES PRIVATE LIMITED Profile snapshot · Sep 2026 ST Shubhendra Thakur Co-Founder & CEO
Highest education DACN
Location Nagpur, Maharashtra, India Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 14 11-50
LinkedIn followers 1,044
LinkedIn page Recent company signals Mar 2026 Award Edward Kennedy Memorial Award — 9th World Cancer Congress 2026Feb 2026 Milestone awarded Breakthrough Device Designation - a global recognition of the device potential to transform early oral cancer diagnostics US FDA BreFrom the company’s LinkedIn posts Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue growth Not reported
Revenue model Physical commerce
Team size 8
Recorded funding US$983k · Seed · Jan 2025
Founded 2018 · about 8 years old
Stage Seed
Focus Drugs, Diversified Revenue over time FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Lamark Biotech Private Limited Funding over time Seed · Mar 2021 Seed '21 Seed · Apr 2023 Seed '23 Seed · Jan 2025 Seed '25 US$983k across 3 disclosed equity rounds
Darker bars = larger rounds Founders · 1 VB Vaibhav Bhatia Founder & CEO
Highest education PhD · Indian Institute of Science
Location Greater Sevilla Metropolitan Area
Current company Lamark Biotech Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 12 2-10
LinkedIn followers 2,376
Open roles 2 of 4 tracked · last posted Aug 2026
LinkedIn page Patents Patent filings 4
Focus: Controlled-release insulin formulations using hydrogel crystal‑seeding technology
CPC C07K14/62 Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Explore India oncology companies by sub-sector The most common specialisations among oncology companies in India. Open a company to see what it sells, who runs it and how far it has come.
Genomics · 20 20 oncology companies in India work in genomics. Shown: the best-documented.
Genomics Positive Bioscience Provider of DNA tests for cancer treatment & hereditary cancer screening
SJ BJ Explore company Oncology Sapien Biosciences Provider of biobanking services to discover biomarkers and develop drugs and companion diagnostics
JJ Explore company Genomics Exsegen Developer of minimally invasive brain cancer diagnostics and treatments
Revenue ₹14.72 lakh FY 2024-25
SM Explore company Oncology Epigeneres Provider of genomics based diagnostic tests for cancer
Revenue ₹7.42 cr FY 2024-25
Founder · 1
AT Explore company Oncology 4baseCare Provider of precision oncology solutions, including genomic testing and digital health
Revenue ₹14.27 cr FY 2024-25
KR Kshitij Rishi Co-Founder & COO
Explore company Oncology OncoStem Developer of prognostic tests for the detection of cancer
Revenue ₹10.02 cr FY 2024-25
Explore company Genomics Kyvor Genomics-based precision cancer diagnostics
Founder · 1
AM Explore company Genomics Datar Genetics Provider of liquid biopsy-based cancer diagnostic test
Revenue ₹102.27 cr FY 2024-25
Explore company Genomics Transgene Biotek Developer of immunotherapies and drug delivery solutions for cancer
Explore company Oncology HMZ Laboratories Provider of cellular diagnostic and molecular screening
Revenue ₹0.66 lakh FY 2021-22
Founder · 1
AK Explore company Oncology ExoCan Exosomes based oncodiagnostics and therapeutics healthcare technology solutions provider
Explore company Life sciences platforms and tools Foresight Biotech Developer of technologies to use nucleic acids as drugs
Revenue ₹13.32 lakh FY 2024-25
SD Sunita Dhar Co-Founder & Director
AM Ashok Manvati Co-Founder & Director
Explore company Full list All 288 genomics companies in India Ranked, with funding, investors and founders. Open the list → Business facts Revenue growth ●●●●
Revenue model Subscription
Team size 11 (previous snapshot 31)
Recorded funding US$466k · Angel · Nov 2018
Founded 2012 · about 14 years old
Stage Seed
Focus In-vitro diagnostic tests, Diversified, Enabling technologies, Kits and reagents Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Positive Biosciences Limited Founders · 3 SJ Samarth Jain Co-Founder & CEO
Highest education MIT Professional Education
Location Mumbai, Maharashtra, India
Current company Positive Bioscience Profile snapshot · Sep 2026 BJ Bapsy Jain Co-Founder & CFO
Location Mumbai, Maharashtra, India
Current company S P Jain School of Global Management Profile snapshot · Sep 2026 MM Meetha Medhora Co-Founder
Highest education Genetics · Washington University In St. Louis
Location Brookfield, Wisconsin, United States Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 14 11-50
LinkedIn followers 3,736
Earlier recorded team 11 2023, a different source
LinkedIn page Technology PHP MySQL Nginx WordPress jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts Revenue growth ●●●●
Revenue model Physical commerce, Subscription
Team size 42
Recorded funding None recorded
Founded 2012 · about 14 years old
Stage Seed
Focus Research services, Biorepository, Gene biobanking, Enabling technologies Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Sapien Biosciences Private Limited Founders · 2 JJ Jugnu Jain Co-Founder & CEO
Highest education PhD, Genetics · University of Cambridge
Location Hyderabad, Telangana, India
Current company Sapien Biosciences Profile snapshot · Sep 2026 VN Vatsa Natarajan Co-Founder & Director
Highest education MSc · BITS Pilani
Location Hyderabad, Telangana, India Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 50 11-50
LinkedIn followers 7,516
Earlier recorded team 42 2024, a different source
LinkedIn page Technology PHP MySQL Sentry WordPress jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹14.72 lakh · FY 2024-25
Revenue growth +1903% · 2024–2025
Revenue model Subscription
Team size Not available
Recorded funding None recorded
Founded 2020 · about 6 years old
Stage Unfunded
Focus In-vitro diagnostic tests, Neurological cancer Revenue over time FY2023 23 FY2024 24 FY2025 25 ₹14.72 lakh in FY24-25 · net −₹47.32 lakh · ●●●●
Filed standalone accounts · Exsegen Genomics Research Private Limited Founders · 2 VP Vikas Pawar Co-Founder & COO
Highest education Master's of Business Administration · University of Pittsburgh
Location Andhra Pradesh, India
Current company Exsegen Genomics Profile snapshot · Sep 2026 SM Surya Madiraju Co-Founder & CFO
Highest education MS, International Business · University of Melbourne
Location Hyderabad, Telangana, India
Current company Exsegen Genomics Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 27 11-50
LinkedIn followers 1,232
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹7.42 cr · FY 2024-25
Revenue growth +185% · 2024–2025
Revenue model E-commerce - product, Physical commerce
Team size 75
Recorded funding US$9.83m · Series B · Jun 2024
Founded 2008 · about 18 years old
Stage Series B
Focus In-vitro diagnostic tests, Pan cancer Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹7.42 cr in FY24-25 · net −₹17.26 cr · +8079% since FY2018
Filed standalone accounts · Epigeneres Biotech Private Limited Funding over time Series A · Apr 2018 A '18 Series B · Dec 2021 B '21 Series B · Jun 2024 B '24 US$9.83m across 3 disclosed equity rounds
Darker bars = larger rounds Founders · 1 AT Ashish Tripathi Founder & Chairman
Highest education Master's of business administration in finance · Melbourne Business School
Location Mumbai, Maharashtra, India
Current company Tzar Labs Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 85 51-200
LinkedIn followers 5,100
Earlier recorded team 75 2024, a different source
Open roles 2 of 3 tracked · last posted May 2026
May 2026 Hiring: Junior Legal ExecutiveApr 2026 Hiring: Clinical Oncology LiaisonApr 2026 Hiring: Business Development Manager · Mumbai, Bengaluru, New DelhiLinkedIn page Technology React Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹14.27 cr · FY 2024-25
Revenue growth Not reported
Revenue model Subscription
Team size 25
Recorded funding US$22.28m · Series B · Jan 2026
Founded 2018 · about 8 years old
Stage Series B
Focus Applied genomics, Clinical genomics, Diagnostics, Sequencing-based Funding over time Angel · Feb 2019 Angel '19 Seed · Mar 2021 Seed '21 Series A · Jul 2024 A '24 Series A · Dec 2024 A '24 Series A · Nov 2025 A '25 Series B · Jan 2026 B '26 US$22.28m across 6 disclosed equity rounds
Darker bars = larger rounds Founders · 2 HG Hitesh Goswami Co-Founder & CEO
Highest education Sophia College, Mumbai
Location Bengaluru, Karnataka, India
Current company 4baseCare Profile snapshot · Sep 2026 KR Kshitij Rishi Co-Founder & COO
Highest education B.E. · Panjab University
Team & hiring signals LinkedIn headcount 322 51-200
LinkedIn followers 39,764
Open roles 4 of 10 tracked · last posted Jul 2026
LinkedIn page Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹10.02 cr · FY 2024-25
Revenue growth +40% · 2024–2025
Revenue model Subscription
Team size 19
Recorded funding US$9.00m · Series A · Sep 2017
Founded 2011 · about 15 years old
Stage Series A
Focus In-vitro diagnostic tests, Women's cancer, Breast cancer, Prognosis Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹10.02 cr in FY24-25 · net ₹3.71 cr · +187% since FY2018
Filed standalone accounts · Oncostem Diagnostics Private Limited Funding over time Seed · Jan 2011 Seed '11 Series A · Sep 2017 A '17 US$9.00m across 2 disclosed equity rounds
Darker bars = larger rounds Founders · 1 MB Manjiri Bakre Founder & CEO
Location Bengaluru, Karnataka, India Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 22 11-50
LinkedIn followers 6,955
Earlier recorded team 19 2024, a different source
LinkedIn page Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts Revenue growth ●●●●
Revenue model Subscription
Team size 11
Recorded funding US$160k · Angel · Jul 2017
Founded 2016 · about 10 years old
Stage Seed
Focus In-vitro diagnostic tests, Pan cancer, Applied genomics, Clinical genomics Revenue over time FY2017 17 FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022: no filing on record 22 FY2023 23 FY2024 24 ●●●● ●●●● ●●●●
Filed standalone accounts · Kyvor Genomics Private Limited Founders · 1 AM Abilesh Malli Gunasekar Founder & CEO
Highest education The University of Manchester
Location Chennai, Tamil Nadu, India
Current company Kyvor Genomics, Inc Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 2 11-50
LinkedIn followers 2,986
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹102.27 cr · FY 2024-25
Revenue growth +31% · 2024–2025
Revenue model Fee-for-service
Team size 175 (previous snapshot 60)
Recorded funding None recorded
Founded 1992 · about 34 years old
Stage Early Stage
Focus Applied genomics, Clinical genomics, Diagnostics, Sequencing-based Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹26.76 cr in FY24-25 · net −₹8.02 cr · +315% since FY2018
Filed standalone accounts · Datar Cancer Genetics Private Limited Founders · 1
Highest education Savitribai Phule Pune University
Location Nasik, Maharashtra, India
Current company Datar Cancer Genetics Limited Profile snapshot · Sep 2026 Technology Cloudflare Bootstrap jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts Revenue growth ●●●●
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding None recorded
Founded 1990 · about 36 years old
Stage Public
Focus Applied genomics, Clinical genomics, Therapeutics, Drugs Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Transgene Biotek Limited. Founders · 1 KR Koteswara Rao Founder & Managing Director
Location Hyderabad, Telangana, India
Current company Transgene Biotek Ltd Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 20 51-200
LinkedIn followers 510
LinkedIn page Patents Patent filings 25
Focus: Advanced oral and nasal peptide drug delivery formulations for insulin and biologics
CPC A61K47/36, A61K38/28, C07K7/08 Technology Cloudflare Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹0.66 lakh · FY 2021-22
Revenue growth Not reported
Revenue model Fee-for-service
Team size Not available
Recorded funding None recorded
Founded 2018 · about 8 years old
Stage Unfunded
Focus In-vitro diagnostic tests, Diversified, Applied genomics, Clinical genomics Founders · 1 AK Andreas Klein Co-Founder & Marketing Director
Location Greater Bielefeld Area
Current company GIGANT GmbH Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 6 11-50
LinkedIn followers 168
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts Revenue growth ●●●●
Revenue model Physical commerce, Subscription
Team size Not available
Recorded funding None recorded
Founded 2015 · about 11 years old
Stage Funding Raised
Focus In-vitro diagnostic tests, Diversified, Applied genomics, Clinical genomics Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Exocan Healthcare Technologies Private Limited Founders · 1 AS Aman Sharma Founder & Director
Location Pune District, Maharashtra, India Profile snapshot · Sep 2026 Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹13.32 lakh · FY 2024-25
Revenue growth +22% · 2024–2025
Revenue model Fee-for-service
Team size Not available
Recorded funding None recorded
Founded 2015 · about 11 years old
Stage Unfunded
Focus Applied genomics, Clinical genomics, Therapeutics, Research services Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹13.32 lakh in FY24-25 · net −₹11.91 lakh · +320% since FY2018
Filed standalone accounts · Foresight Biotech Private Limited Founders · 3 SD Sunita Dhar Co-Founder & Director
AM Ashok Manvati Co-Founder & Director
Team & hiring signals LinkedIn headcount 7 2-10
LinkedIn followers 787
Open roles 1 of 1 tracked · last posted Jun 2026
Jun 2026 Internship: Internship & Training Program 2026LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Immunotherapy · 16 16 oncology companies in India work in immunotherapy. Shown: the best-documented.
Oncology ImmunoACT Developer of cell and gene therapies for cancer treatment
Revenue ₹67.57 cr FY 2024-25
RP SA Shirish Arya Co-Founder & Director - Corporate Strategy & Business Development
Explore company Immunotherapy Zumutor Developer of novel immunotherapy and monoclonal antibody therapeutics
Revenue ₹4.63 cr FY 2024-25
KI Explore company Cell therapy NKure Theraputics Developer of NK cell therapies for the treatment of cancer
AV Explore company Oncology Immuneel Developer of T-cell therapies for the treatment of cancer
Revenue ₹9.92 cr FY 2024-25
Founder · 1
SM Explore company Immunotherapy Curadev Pharma Developer of small molecule immunotherapy drugs for cancer and inflammation
Revenue ₹14.08 cr FY 2024-25
Explore company Genomics Transgene Biotek Developer of immunotherapies and drug delivery solutions for cancer
Explore company Oncology Ricaptos Developer of drugs for oncology, cardiovascular, gastroenterology disease, and infectious diseases
Explore company Immunotherapy Invictus Oncology Developer of chemotherapeutics conjugated with antibodies for the treatment of cancer
Founder · 1
RM Raghunath Mashelkar Co-Founder
Explore company Immunotherapy APAC Biotech Developer of autologous monocyte-derived dendritic cell immunotherapy for cancer
Explore company Oncology CuraTeQ Biologics Developer of immuno-oncology therapeutics
Revenue ₹9.49 cr FY 2024-25
Explore company Immunology Lextro Labs Provider of biotherapeutics for immunological disorders
Revenue model E-commerce - product / Physical commerce
AC Akkina Chowdary Co-Founder & Managing Director
Explore company Infectious diseases Luxmatra Developer of nanotechnology-based therapeutics
Revenue model Subscription
Explore company Business facts
Revenue ₹67.57 cr · FY 2024-25
Revenue growth +510% · 2024–2025
Revenue model Fee-for-service
Team size 139
Recorded funding US$15.87m · Series B · May 2023
Founded 2018 · about 8 years old
Stage Series B
Focus Drugs, Blood cancer Revenue over time FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹67.57 cr in FY24-25 · net ₹10.18 cr · +287274% since FY2021
Filed standalone accounts · Immunoadoptive Cell Therapy Private Limited Funding over time Series A · Nov 2021 A '21 Series B · May 2023 B '23 US$15.87m across 2 disclosed equity rounds
Darker bars = larger rounds Founders · 3 AK Atharva Karulkar Co-Founder
Highest education Doctor of Philosophy · Indian Institute of Technology Bombay
Location Mumbai, Maharashtra, India Profile snapshot · Sep 2026 RP Rahul Purwar Co-Founder & CEO
Highest education Master's of Science · University of Lucknow
Location Mumbai, Maharashtra, India
Current company Indian Institute of Technology, Bombay Profile snapshot · Sep 2026 SA Shirish Arya Co-Founder & Director - Corporate Strategy & Business Development
Highest education MBA · IMDR
Team & hiring signals LinkedIn headcount 193 51-200
LinkedIn followers 37,682
Earlier recorded team 139 2024, a different source
Open roles 1 of 5 tracked · last posted Jun 2026
Jun 2026 Hiring: Receptionist · Navi Mumbai, MaharashtraJun 2026 Hiring: Strategic Accounts Lead · Cambridge, Navi Mumbai, MaharashtraLinkedIn page Recent company signals Jun 2026 Milestone 750+ patients treatedFrom the company’s LinkedIn posts Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹4.63 cr · FY 2024-25
Revenue growth -64% · 2024–2025
Revenue model Fee-for-service
Team size 24 (previous snapshot 37)
Recorded funding US$27.89m · Series A · Nov 2024
Founded 2013 · about 13 years old
Stage Series A
Focus Drugs, Diversified, Immuno oncology Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹4.63 cr in FY24-25 · net −₹3.90 cr · -52% since FY2018
Filed standalone accounts · Zumutor Biologics Private Limited Funding over time Seed · Jan 2013 Seed '13 Series A · Jan 2015 A '15 Series A · Apr 2018 A '18 Series A · Nov 2019 A '19 Series A · Aug 2021 A '21 Series A · Oct 2022 A '22 Series A · Feb 2024 A '24 Series A · Nov 2024 A '24 US$27.89m across 8 disclosed equity rounds
Darker bars = larger rounds Founders · 2 KI Kavitha Iyer Rodrigues Co-Founder & CEO
Highest education Master's of Business Administration, Management · Indian Institute of Management Bangalore
Location Greater Bengaluru Area
Current company Zumutor Biologics Inc. Profile snapshot · Sep 2026
Highest education Wright State University Boonshoft School Of Medicine
Location Bengaluru, Karnataka, India
Current company Zumutor Biologics Inc. Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 25 11-50
LinkedIn followers 8,561
Earlier recorded team 24 2023, a different source
LinkedIn page Technology PHP MySQL Cloudflare WordPress Bootstrap Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts Revenue growth ●●●●
Revenue model Fee-for-service
Team size 3
Recorded funding US$2.15m · Seed · Oct 2023
Founded 2021 · about 5 years old
Stage Seed
Focus Drugs, Diversified Revenue over time FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Nkure Therapeutics Private Limited Funding over time Seed · Dec 2022 Seed '22 Seed · Apr 2023 Seed '23 Seed · Oct 2023 Seed '23 US$2.15m across 3 disclosed equity rounds
Darker bars = larger rounds Founders · 2 AV Ashok Vohra Co-Founder
Highest education BSc, Engineering · Greater Brighton Metropolitan College
Location Bengaluru, Karnataka, India
Current company NKure Therapeutics Profile snapshot · Sep 2026
Highest education Caltech
Location Washington DC-Baltimore Area
Current company Forza Bio Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 15 2-10
LinkedIn followers 1,676
LinkedIn page Recent company signals Nov 2025 Award Best poster award — DBR MAHE Cell Therapy ConclaveFrom the company’s LinkedIn posts Technology PHP MySQL WordPress Bootstrap jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹9.92 cr · FY 2024-25
Revenue growth +342% · 2024–2025
Revenue model Fee-for-service
Team size 67 (previous snapshot 50)
Recorded funding US$39.34m · Series A · Jun 2024
Founded 2018 · about 8 years old
Stage Series A
Focus Drugs, Diversified Revenue over time FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹9.92 cr in FY24-25 · net −₹40.46 cr · +1378% since FY2020
Filed standalone accounts · Immuneel Therapeutics Private Limited Funding over time Series A · Nov 2019 A '19 Series A · Sep 2020 A '20 Series A · Apr 2022 A '22 Series A · Jun 2024 A '24 US$39.34m across 4 disclosed equity rounds
Darker bars = larger rounds Founders · 1 SM Siddhartha Mukherjee Co-Founder
Location New York, New York, United States
Current company Columbia University Medical Center Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 112 51-200
LinkedIn followers 73,120
Earlier recorded team 67 2024, a different source
LinkedIn page Recent company signals Jun 2026 Leadership Hired a Associate Director – Global Market AccessFrom the company’s LinkedIn posts Technology PHP MySQL Salesforce WordPress Bootstrap Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹14.08 cr · FY 2024-25
Revenue growth +24% · 2024–2025
Revenue model Fee-for-service
Team size 38 (previous snapshot 40)
Recorded funding US$881k · Angel · Mar 2011
Founded 2010 · about 16 years old
Stage Seed
Focus Drugs, Diversified Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹14.08 cr in FY24-25 · net −₹20.93 cr · +580% since FY2018
Filed standalone accounts · Curadev Pharma Private Limited Founders · 2
Highest education MS · Indian Institute of Technology Kanpur
MT Manish Tandon Director and Co-Founder
Highest education Wharton Executive Education
Location Boston, Massachusetts, United States
Current company CURADEV PHARMA Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 42 51-200
LinkedIn followers 9,006
Earlier recorded team 38 2024, a different source
Open roles 3 of 4 tracked · last posted Jul 2026
Jun 2026 Hiring: Research Biologist · Noida, Uttar PradeshJun 2026 Hiring: Laboratory Technician · Noida, Uttar Pradesh, IndiaMay 2026 Hiring: Clinical Trial Assistant (CTA) · Noida / New DelhiLinkedIn page Patents Patent filings 87
Focus: Small‑molecule STING antagonists and ACSS2 inhibitors for immuno‑oncology therapy
CPC C07D333/66, C07D417/12, C08B37/0012 Technology Google Cloud React Sentry Bootstrap Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts Revenue growth ●●●●
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding None recorded
Founded 1990 · about 36 years old
Stage Public
Focus Applied genomics, Clinical genomics, Therapeutics, Drugs Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Transgene Biotek Limited. Founders · 1 KR Koteswara Rao Founder & Managing Director
Location Hyderabad, Telangana, India
Current company Transgene Biotek Ltd Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 20 51-200
LinkedIn followers 510
LinkedIn page Patents Patent filings 25
Focus: Advanced oral and nasal peptide drug delivery formulations for insulin and biologics
CPC A61K47/36, A61K38/28, C07K7/08 Technology Cloudflare Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts Revenue growth ●●●●
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding None recorded
Founded 2019 · about 7 years old
Stage Unfunded
Focus Drugs, Diversified Revenue over time FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Ricaptos Biocare Private Limited Founders · 1
Location Bengaluru, Karnataka, India
Current company Ricaptos Biocare Pvt Ltd. Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 1 201-500
LinkedIn followers 15
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts Revenue growth ●●●●
Revenue model E-commerce - product, Physical commerce
Team size 38
Recorded funding US$6.99m · Series A · Oct 2016
Founded 2011 · about 15 years old
Stage Series A
Focus Drugs, Diversified Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Invictus Oncology Private Limited Funding over time Series A · Feb 2013 A '13 Series A · May 2014 A '14 Series A · Aug 2015 A '15 Series A · Jun 2016 A '16 Series A · Oct 2016 A '16 US$6.99m across 5 disclosed equity rounds
Darker bars = larger rounds Founders · 1 RM Raghunath Mashelkar Co-Founder
Team & hiring signals LinkedIn headcount 16 2-10
LinkedIn followers 523
Earlier recorded team 38 2019, a different source
LinkedIn page Patents Patent filings 51
Focus: Lipid‑nanoparticle delivery of platinum chemotherapeutics and signaling‑inhibitor therapeutics
CPC C07F15/0093, A61K31/337, A61K47/60 Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts Revenue growth ●●●●
Revenue model Physical commerce
Team size Not available
Recorded funding US$991k · Seed · Mar 2011
Founded 2010 · about 16 years old
Stage Seed
Focus Drugs, Diversified Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Apac Biotech Private Limited Investors · 1 Projects Development Fund
Technology Google Cloud React Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹9.49 cr · FY 2024-25
Revenue growth Not reported
Revenue model E-commerce - product, Physical commerce
Team size 535
Recorded funding None recorded
Founded 2020 · about 6 years old
Stage Unfunded
Focus Drugs, Diversified, Immuno oncology Revenue over time FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹9.49 cr in FY24-25 · net −₹812.07 cr · -81% since FY2021
Filed standalone accounts · Curateq Biologics Private Limited Team & hiring signals LinkedIn headcount 696 501-1,000
LinkedIn followers 19,558
Earlier recorded team 535 2024, a different source
Open roles 0 of 1 tracked · last posted Apr 2025
LinkedIn page Recent company signals Sep 2025 Milestone completed Phase III clinical study completedFrom the company’s LinkedIn posts Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue Not reported
Revenue growth Not reported
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding None recorded
Founded 2022 · about 4 years old
Stage Unfunded
Focus Drugs, Autoimmune diseases, Diversified Founders · 2 AC Akkina Chowdary Co-Founder & Managing Director
MA Murali Addepalli Co-Founder
Highest education MSc · University of Hyderabad
Location Hyderabad, Telangana, India
Current company SANSHI Bio Solutions Private Limited Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 1 11-50
LinkedIn followers 43
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue Not reported
Revenue growth Not reported
Revenue model Subscription
Team size Not available
Recorded funding None recorded
Founded 2016 · about 10 years old
Stage Funding Raised
Focus Diversified, Drugs, Nanoparticle based, Viral Founders · 1 MK Manzoor Koyakutty Co-Founder
Highest education Cochin University of Science and Technology
Location Ernakulam, Kerala, India
Current company The Johns Hopkins University School of Medicine Profile snapshot · Sep 2026 Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Infectious diseases · 9 9 oncology companies in India work in infectious diseases. Shown: the best-documented.
Infectious diseases Bugworks Research Developer of drugs for antibiotic-resistant bacterial infections and cancer
Revenue ₹25.18 cr FY 2024-25
SD Explore company Oncology Luxmatra Developer of therapeutics for multiple diseases
GC Explore company Infectious diseases Hemogenomics Provider of blood screening technology for the early detection of diseases
Revenue ₹102.89 cr FY 2024-25
Leadership · 1
SB Explore company Diabetes Sekkei Bio Developer of drugs and vaccines to treat multiple diseases
Revenue ₹7.55 cr FY 2024-25
Founder · 1
MC Explore company Infectious diseases Prosetta Developer of anti-viral therapies
Founder · 1
KM Explore company Oncology Sathgen Therapeutics Developer of therapeutics for cancer and viral infection
Revenue model Fee-for-service
SM Explore company Immunology Lextro Labs Provider of biotherapeutics for immunological disorders
Revenue model E-commerce - product / Physical commerce
AC Akkina Chowdary Co-Founder & Managing Director
Explore company Oncology Immortalight Developer of medical diagnostic tools and therapeutic drugs, plus agriculture app
Revenue model E-commerce - product / Physical commerce
Explore company Infectious diseases Luxmatra Developer of nanotechnology-based therapeutics
Revenue model Subscription
Explore company Full list All 102 infectious diseases companies in India Ranked, with funding, investors and founders. Open the list → Business facts
Revenue ₹25.18 cr · FY 2024-25
Revenue growth -12% · 2024–2025
Revenue model Physical commerce
Team size 31 (previous snapshot 45)
Recorded funding US$42.89m · Series B · Feb 2024
Founded 2014 · about 12 years old
Stage Series B
Focus Drugs, Bacterial, Drug resistant infections, Diversified Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹25.18 cr in FY24-25 · net ₹2.46 cr · +282% since FY2018
Filed standalone accounts · Bugworks Research India Private Limited Funding over time Seed · Nov 2015 Seed '15 Series A · Aug 2018 A '18 Series B · Apr 2020 B '20 Series B · Dec 2021 B '21 Series B · Feb 2024 B '24 US$42.89m across 5 disclosed equity rounds
Darker bars = larger rounds Founders · 3 BS Bala Subramanian Co-Founder & COO
Highest education BSc · Loyola College
Location Bengaluru, Karnataka, India Profile snapshot · Sep 2026 SD Santanu Datta Co-Founder
Highest education Calcutta University, Kolkata
Location Bengaluru, Karnataka, India
Current company Bugworks Research Inc. Profile snapshot · Sep 2026 AA Anand Anandkumar Co-Founder & CEO
Highest education Doctor of Philosophy · The George Washington University Team & hiring signals LinkedIn headcount 47 11-50
LinkedIn followers 11,353
Earlier recorded team 31 2023, a different source
LinkedIn page Recent company signals Apr 2026 Milestone global patenting of BWC2094 program BWC2094 patentingFrom the company’s LinkedIn posts Technology PHP MySQL Cloudflare WordPress jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue growth Not reported
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding None recorded
Founded Not available
Stage Funding Raised
Focus Drugs, Diversified, Immuno oncology Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Luxmatrainnovations Private Limited Founders · 2 MK Manzoor Koyakutty Co-Founder & Director
Highest education Cochin University of Science and Technology
Location Ernakulam, Kerala, India
Current company The Johns Hopkins University School of Medicine Profile snapshot · Sep 2026 GC Girish C M Co-Founder & COO
Highest education MIT Professional Education
Location Ernakulam, Kerala, India
Current company Luxmatra Innovations Profile snapshot · Sep 2026 Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹102.89 cr · FY 2024-25
Revenue growth +3% · 2024–2025
Revenue model Subscription
Team size 98
Recorded funding US$219k · Seed · Aug 2008
Founded 2002 · about 24 years old
Stage Seed
Focus In-vitro diagnostic tests, Diversified, In vitro diagnostic tests, Viral Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹102.89 cr in FY24-25 · net ₹7.08 cr · +106% since FY2018
Filed standalone accounts · Hemogenomics Private Limited Leadership · 1 SB Sumit Bagaria CEO & MD
Highest education Master's of business administration in marketing · Indian Institute Of Management, Calcutta
Location Greater Bengaluru Area
Current company Hemogenomics Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 125 51-200
LinkedIn followers 3,705
Earlier recorded team 98 2024, a different source
LinkedIn page Technology PHP MySQL Cloudflare WordPress Bootstrap Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹7.55 cr · FY 2024-25
Revenue growth +255% · 2024–2025
Revenue model Fee-for-service
Team size Not available
Recorded funding US$2.03m · Seed · Feb 2021
Founded 2017 · about 9 years old
Stage Series A
Focus Drugs, Diversified, Viral Revenue over time FY2019 19 FY2020 20 FY2021: no filing on record 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹7.55 cr in FY24-25 · net −₹1.96 cr · +6190% since FY2019
Filed standalone accounts · Sekkei Bio Private Limited Funding over time Series A · Jan 2021 A '21 Seed · Feb 2021 Seed '21 US$2.03m across 2 disclosed equity rounds
Darker bars = larger rounds Founders · 1 MC Monalisa Chatterji Co-Founder
Highest education MSc · Indian Institute of Science
Location Bangalore Urban, Karnataka, India
Current company Sekkei Bio Private Limited Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 22 11-50
LinkedIn followers 2,736
Open roles 1 of 2 tracked · last posted Apr 2026
Apr 2026 Hiring: Upstream ScientistApr 2026 Hiring: Project Lead · Bangalore, IndiaLinkedIn page Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts Revenue growth ●●●●
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding None recorded
Founded 2004 · about 22 years old
Stage Unfunded
Focus Drugs, Diversified, Neurodegenerative Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Prosetta Bio-Conformatics Private Limited Founders · 1 KM Karl Manheim Co-Founder
Location Los Angeles, California, United States
Current company Seldom Here Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 4
LinkedIn followers 41
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue Not reported
Revenue growth Not reported
Revenue model Fee-for-service
Team size 52
Recorded funding None recorded
Founded 2007 · about 19 years old
Stage Unfunded
Focus Drugs, Diversified, Viral, Covid-19 Founders · 2 SM Sendurai Mani Co-Founder
Location Providence, Rhode Island, United States
Current company Brown University Profile snapshot · Sep 2026 SS Samir Somaiya Co-Founder
Highest education Master's of Public Administration · Harvard University Team & hiring signals LinkedIn headcount 2 51-200
LinkedIn followers 466
Earlier recorded team 52 2024, a different source
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue Not reported
Revenue growth Not reported
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding None recorded
Founded 2022 · about 4 years old
Stage Unfunded
Focus Drugs, Autoimmune diseases, Diversified Founders · 2 AC Akkina Chowdary Co-Founder & Managing Director
MA Murali Addepalli Co-Founder
Highest education MSc · University of Hyderabad
Location Hyderabad, Telangana, India
Current company SANSHI Bio Solutions Private Limited Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 1 11-50
LinkedIn followers 43
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue Not reported
Revenue growth Not reported
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding None recorded
Founded 2020 · about 6 years old
Stage Unfunded
Focus Diversified, Drugs, In vitro diagnostic tests, Sars-cov-2 Founders · 1 SB Swetha Bobba Founder, CEO & MD
Location Hyderabad, Telangana, India
Current company IMMORTALIGHT LTD. Profile snapshot · Sep 2026 Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue Not reported
Revenue growth Not reported
Revenue model Subscription
Team size Not available
Recorded funding None recorded
Founded 2016 · about 10 years old
Stage Funding Raised
Focus Diversified, Drugs, Nanoparticle based, Viral Founders · 1 MK Manzoor Koyakutty Co-Founder
Highest education Cochin University of Science and Technology
Location Ernakulam, Kerala, India
Current company The Johns Hopkins University School of Medicine Profile snapshot · Sep 2026 Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Clinical genomics · 9 9 oncology companies in India work in clinical genomics. Shown: the best-documented.
Genomics Positive Bioscience Provider of DNA tests for cancer treatment & hereditary cancer screening
SJ BJ Explore company Oncology Tvaster Genkalp Developer of epigenetic-based liquid biopsy tests for cancer detection. This company provides molecular diagnostic solutions focusing on identifying genetic and epigenetic modifications to aid oncologists in making informed treatment decisions. The tests utilize a minimally invasive blood sample to diagnose and understand genetic and epigenetic alterations, enabling personalized healthcare decisions. The technology combines epigenetics, liquid biopsy, and digital droplet PCR for efficient cancer screening. The company's mission is to provide clinically relevant information to improve the quali
SR SK Explore company Oncology OncoStem Developer of prognostic tests for the detection of cancer
Revenue ₹10.02 cr FY 2024-25
Explore company Genomics Kyvor Genomics-based precision cancer diagnostics
Founder · 1
AM Explore company Genomics Datar Genetics Provider of liquid biopsy-based cancer diagnostic test
Revenue ₹102.27 cr FY 2024-25
Explore company Oncology HMZ Laboratories Provider of cellular diagnostic and molecular screening
Revenue ₹0.66 lakh FY 2021-22
Founder · 1
AK Explore company Clinical genomics TZAR Labs Laboratory focused on providing preventive and diagnostic medicine services for cancer
Revenue SGD 6k FY 2023-24
Founder · 1
AT Ashish Tripathi Founder & CEO
Explore company Genomics OncoDiscover Provider of liquid biopsy test for the detection of cancer
Revenue model E-commerce - product / Physical commerce
AV Explore company Genomics CellMax Life Provider of sequence-based diagnostic solutions for cancer
Revenue model Fee-for-service
Founder · 1
AS Atul Sharan Co-Founder & CEO
Explore company Full list All 63 clinical genomics companies in India Ranked, with funding, investors and founders. Open the list → Business facts Revenue growth ●●●●
Revenue model Subscription
Team size 11 (previous snapshot 31)
Recorded funding US$466k · Angel · Nov 2018
Founded 2012 · about 14 years old
Stage Seed
Focus In-vitro diagnostic tests, Diversified, Enabling technologies, Kits and reagents Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Positive Biosciences Limited Founders · 3 SJ Samarth Jain Co-Founder & CEO
Highest education MIT Professional Education
Location Mumbai, Maharashtra, India
Current company Positive Bioscience Profile snapshot · Sep 2026 BJ Bapsy Jain Co-Founder & CFO
Location Mumbai, Maharashtra, India
Current company S P Jain School of Global Management Profile snapshot · Sep 2026 MM Meetha Medhora Co-Founder
Highest education Genetics · Washington University In St. Louis
Location Brookfield, Wisconsin, United States Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 14 11-50
LinkedIn followers 3,736
Earlier recorded team 11 2023, a different source
LinkedIn page Technology PHP MySQL Nginx WordPress jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts Revenue growth ●●●●
Revenue model Advertising, Commission on transaction, E-commerce - product
Team size 4
Recorded funding US$2.57m · Seed · Apr 2025
Founded 2021 · about 5 years old
Stage Seed
Focus In-vitro diagnostic tests, Gastrointestinal cancer, Liver cancer, In vitro diagnostic tests Revenue over time FY2023 23 FY2024 24 FY2025 25 ●●●● ●●●● ●●●●
Filed standalone accounts · Tvaster Genkalp Private Limited Funding over time Seed · Sep 2023 Seed '23 Seed · Apr 2025 Seed '25 US$2.57m across 2 disclosed equity rounds
Darker bars = larger rounds Founders · 2 SR Srikar Raman Co-Founder & CEO
Highest education Doctorates in mechanical engineering · University Of Illinois At Chicago
Location Chennai, Tamil Nadu, India
Current company Tvaster Genkalp Profile snapshot · Sep 2026 SK Sreedurgalakshmi K Co-Founder
Highest education Master's of Technology · SRM
Location Chennai, Tamil Nadu, India
Current company Tvaster Genkalp Profile snapshot · Sep 2026 Investors · 4 IS Invigo Softwares Fund
RH Rela Hospitals Fund
MR Mohamed Rela Angel
Patents Patent filings 3
Focus: Epigenetic diagnostic kits detecting carcinomas via methylation markers without sequencing
CPC C12Q1/6886, C12Q1/6858 Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹10.02 cr · FY 2024-25
Revenue growth +40% · 2024–2025
Revenue model Subscription
Team size 19
Recorded funding US$9.00m · Series A · Sep 2017
Founded 2011 · about 15 years old
Stage Series A
Focus In-vitro diagnostic tests, Women's cancer, Breast cancer, Prognosis Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹10.02 cr in FY24-25 · net ₹3.71 cr · +187% since FY2018
Filed standalone accounts · Oncostem Diagnostics Private Limited Funding over time Seed · Jan 2011 Seed '11 Series A · Sep 2017 A '17 US$9.00m across 2 disclosed equity rounds
Darker bars = larger rounds Founders · 1 MB Manjiri Bakre Founder & CEO
Location Bengaluru, Karnataka, India Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 22 11-50
LinkedIn followers 6,955
Earlier recorded team 19 2024, a different source
LinkedIn page Technology Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts Revenue growth ●●●●
Revenue model Subscription
Team size 11
Recorded funding US$160k · Angel · Jul 2017
Founded 2016 · about 10 years old
Stage Seed
Focus In-vitro diagnostic tests, Pan cancer, Applied genomics, Clinical genomics Revenue over time FY2017 17 FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022: no filing on record 22 FY2023 23 FY2024 24 ●●●● ●●●● ●●●●
Filed standalone accounts · Kyvor Genomics Private Limited Founders · 1 AM Abilesh Malli Gunasekar Founder & CEO
Highest education The University of Manchester
Location Chennai, Tamil Nadu, India
Current company Kyvor Genomics, Inc Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 2 11-50
LinkedIn followers 2,986
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹102.27 cr · FY 2024-25
Revenue growth +31% · 2024–2025
Revenue model Fee-for-service
Team size 175 (previous snapshot 60)
Recorded funding None recorded
Founded 1992 · about 34 years old
Stage Early Stage
Focus Applied genomics, Clinical genomics, Diagnostics, Sequencing-based Revenue over time FY2018 18 FY2019 19 FY2020 20 FY2021 21 FY2022 22 FY2023 23 FY2024 24 FY2025 25 ₹26.76 cr in FY24-25 · net −₹8.02 cr · +315% since FY2018
Filed standalone accounts · Datar Cancer Genetics Private Limited Founders · 1
Highest education Savitribai Phule Pune University
Location Nasik, Maharashtra, India
Current company Datar Cancer Genetics Limited Profile snapshot · Sep 2026 Technology Cloudflare Bootstrap jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue ₹0.66 lakh · FY 2021-22
Revenue growth Not reported
Revenue model Fee-for-service
Team size Not available
Recorded funding None recorded
Founded 2018 · about 8 years old
Stage Unfunded
Focus In-vitro diagnostic tests, Diversified, Applied genomics, Clinical genomics Founders · 1 AK Andreas Klein Co-Founder & Marketing Director
Location Greater Bielefeld Area
Current company GIGANT GmbH Profile snapshot · Sep 2026 Team & hiring signals LinkedIn headcount 6 11-50
LinkedIn followers 168
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue SGD 6k · FY 2023-24
Revenue growth -93% · 2023–2024
Revenue model Fee-for-service
Team size Not available
Recorded funding None recorded
Founded 2019 · about 7 years old
Stage Funding Raised
Focus In-vitro diagnostic tests, Pan cancer, Applied genomics, Clinical genomics Revenue growth Latest revenue SGD 6k FY 2023-24
Reported compound annual growth Founders · 1 AT Ashish Tripathi Founder & CEO
Technology Bootstrap jQuery Detected on the company website Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue Not reported
Revenue growth Not reported
Revenue model E-commerce - product, Physical commerce
Team size Not available
Recorded funding None recorded
Founded 2013 · about 13 years old
Stage Unfunded
Focus In-vitro diagnostic tests, Diversified, Applied genomics, Clinical genomics Founders · 2 JK Jayant Khandare Co-Founder& CSO
Highest education Doctor of Philosophy · University of Mumbai
Location Berlin Metropolitan Area
Current company Actorius Innovations and Research Pvt Ltd Profile snapshot · Sep 2026 AV Aravindan Vasudevan Co-Founder & CEO
Highest education Master's of Science, Chemistry · University of Mumbai
Location Pune, Maharashtra, India
Current company Actorius Innovations and Research Pvt Ltd Profile snapshot · Sep 2026 Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Business facts
Revenue Not reported
Revenue growth Not reported
Revenue model Fee-for-service
Team size 20
Recorded funding None recorded
Founded 2012 · about 14 years old
Stage Funding Raised
Focus Applied genomics, Clinical genomics, Diagnostics, Sequencing-based Founders · 1 AS Atul Sharan Co-Founder & CEO
Team & hiring signals LinkedIn headcount 26 51-200
LinkedIn followers 4,689
LinkedIn page Each tile appears only where data is on record. Founder photos and LinkedIn links appear where a profile matches exactly.
Company lists
PHP
MySQL
Cloudflare
WordPress
Bootstrap
jQuery
Nginx
Webflow
Google Cloud
React
Sentry
Salesforce
Firebase
Node.js
Express
Genomics
Oncology
Oncology
Oncology
Tailwind CSS
Oncology
Vue.js
Oncology
Oncology
Oncology
Oncology
Immunology
Oncology
Oncology
Oncology
Genomics
Oncology
Infectious diseases
Oncology
Oncology
Clinical genomics
Genomics
Genomics